Form990
Click to see attachment
Department of the TreasuryInternal Revenue Service
Return of Organization Exempt From Income Tax
Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except private
foundations)
MediumBullet Do not enter social security numbers on this form as it may be made public.
MediumBullet Information about Form 990 and its instructions is at www.IRS.gov/form990.
OMB No. 1545-0047
2015
Open to Public Inspection
A For the 2015 calendar year, or tax year beginning 01-01-2015 , and ending 12-31-2015
BCheck if applicable:
CName of organization
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC
 
% PRESTON W CAMPBELL MD
Doing business as
 
 
Number and street (or P.O. box if mail is not delivered to street address)
6931 ARLINGTON ROAD Suite 200
 
Room/suite
City or town, state or province, country, and ZIP or foreign postal code
BETHESDA, MD20814
D Employer identification number

91-2059167
E Telephone number

G Gross receipts $ 124,281,169
F Name and address of principal officer:
PRESTON W CAMPBELL MD
6931 ARLINGTON ROAD STE 200
BETHESDA,MD20814
I
Tax-exempt status: (   ) LeftBullet (insert no.) or
J
Website:MediumBullet
WWW.CFF.ORG/RESEARCH/CFFT/
H(a)
Is this a group return for
subordinates?
H(b)
Are all subordinates
included?
If "No," attach a list. (see instructions)
H(c)
Group exemption number MediumBullet  
K Form of organization:  
L Year of formation: 2000
M State of legal domicile: MD
Part I
Summary
Activities & Governance 1 Briefly describe the organization’s mission or most significant activities: THE MISSION IS TO CURE CYSTIC FIBROSIS AND TO PROVIDE ALL PEOPLE WITH THE DISEASE THE OPPORTUNITY TO LEAD FULL, PRODUCTIVE LIVES.
2 Check this box MediumBullet
3 Number of voting members of the governing body (Part VI, line 1a) ........ 3 8
4 Number of independent voting members of the governing body (Part VI, line 1b) ..... 4 7
5 Total number of individuals employed in calendar year 2015 (Part V, line 2a) ...... 5 39
6 Total number of volunteers (estimate if necessary) ............. 6 0
7a Total unrelated business revenue from Part VIII, column (C), line 12 ........ 7a 0
b Net unrelated business taxable income from Form 990-T, line 34 ......... 7b 0
Revenues Prior Year Current Year
8 Contributions and grants (Part VIII, line 1h) ......... 0 86,230,120
9 Program service revenue (Part VIII, line 2g) ......... 3,274,846,429 120,217
10 Investment income (Part VIII, column (A), lines 3, 4, and 7d ) .... 25,502 0
11 Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e) 9,066 37,930,832
12 Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12) 3,274,880,997 124,281,169
Expenses; 13 Grants and similar amounts paid (Part IX, column (A), lines 1–3 )... 3,231,024,082 62,018,896
14 Benefits paid to or for members (Part IX, column (A), line 4)..... 0 0
15 Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10) 6,801,253 9,002,193
16a Professional fundraising fees (Part IX, column (A), line 11e) ..... 0 0
b Total fundraising expenses (Part IX, column (D), line 25) MediumBullet0    
17 Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e).... 37,055,662 53,260,080
18 Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25) 3,274,880,997 124,281,169
19 Revenue less expenses. Subtract line 18 from line 12.......   0
Net Assets or Fund Balances; Beginning of Current Year End of Year
20 Total assets (Part X, line 16)............. 63,052,423 85,794,978
21 Total liabilities (Part X, line 26)............. 63,052,423 85,794,978
22 Net assets or fund balances. Subtract line 21 from line 20..... 0 0
Part II
Signature Block
Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than officer) is based on all information of which preparer has any knowledge.
Sign Here
JumboBullet
Signature of officer Date
JumboBullet
Type or print name and title
Paid Preparer Use Only
Print/Type preparer's name
Preparer's signature
Date
PTIN
Firm's name MediumBullet
Firm's EIN MediumBullet
Firm's address MediumBullet



Phone no.
May the IRS discuss this return with the preparer shown above? (see instructions) ..........
For Paperwork Reduction Act Notice, see the separate instructions.
Cat. No. 11282Y Form 990 (2015)
Form 990 (2015)
Page 2
Part III
Statement of Program Service Accomplishments
Check if Schedule O contains a response or note to any line in this Part III ..............
1
Briefly describe the organization’s mission: THE MISSION OF THE CYSTIC FIBROSIS FOUNDATION THERAPEUTICS IS TO CURE CYSTIC FIBROSIS AND TO PROVIDE ALL PEOPLE WITH THE DISEASE THE OPPORTUNITY TO LEAD FULL, PRODUCTIVE LIVES BY FUNDING RESEARCH AND DRUG DEVELOPMENT AND PROMOTING INDIVIDUALIZED TREATMENT. A LIFE-SHORTENING GENETIC DISEASE, CF AFFECTS THE LUNGS AND DIGESTIVE SYSTEMS OF MORE THAN 30,000 PEOPLE IN THE U.S. CURRENTLY, THERE IS NO CURE.
2
Did the organization undertake any significant program services during the year which were not listed on
the prior Form 990 or 990-EZ? .....................
If "Yes," describe these new services on Schedule O.
3
Did the organization cease conducting, or make significant changes in how it conducts, any program
services? ...........................
If "Yes," describe these changes on Schedule O.
4
Describe the organization’s program service accomplishments for each of its three largest program services, as measured by expenses. Section 501(c)(3) and 501(c)(4) organizations are required to report the amount of grants and allocations to others, the total expenses, and revenue, if any, for each program service reported.
4a (Code:   ) (Expenses $ 56,638,070 including grants of $   ) (Revenue $   )
INVESTMENTS BY CYSTIC FIBROSIS FOUNDATION THERAPEUTICS (CFFT) IN STATE-OF-THE-ART RESEARCH HAVE ACCELERATED PROGRESS TOWARD DEVELOPING NEW CF TREATMENTS AND FINDING A CURE FOR THE DISEASE. BY FUNDING CF DRUG DISCOVERY AND DEVELOPMENT RESEARCH CONDUCTED BY BIOTECHNOLOGY COMPANIES AND PROVIDING MATCHING AWARDS TO CF DRUG DEVELOPERS FOR CF RESEARCH, AND WITH A SPECIALIZED CF CLINICAL TRIALS NETWORK, CFFT HAS ATTRACTED SIGNIFICANT INDUSTRY INVOLVEMENT IN THE FIGHT AGAINST CF. CFFT ACCOMPLISHES ITS MISSION BY FUNDING LIFE-SAVING RESEARCH TO DEVELOP EFFECTIVE THERAPIES FOR PEOPLE WITH CF. CFFT HAS FUNDED HUNDREDS OF MILLIONS OF DOLLARS OF RESEARCH COSTS TO HELP DEVELOP CF DRUGS AND THERAPIES. THROUGH CFFTS EFFORTS, THE LIFE EXPECTANCY OF PEOPLE WITH CF HAS DOUBLED IN THE LAST 30 YEARS, AND RESEARCH TO FIND A CURE IS MORE PROMISING THAN EVER BEFORE.
4b (Code:   ) (Expenses $ 66,442,579 including grants of $ 62,018,896 ) (Revenue $ 120,217 )
CFFT SUPPORTS A NATIONAL CLINICAL RESEARCH NETWORK OF NEARLY 80 FOUNDATION-ACCREDITED CARE CENTERS THAT COLLABORATE TO CONDUCT CLINICAL TRIALS, ALLOWING POTENTIAL NEW CF THERAPIES TO MOVE TO LARGER, LATE-STAGE STUDIES MORE QUICKLY. MEDICAL PROGRAMS IN 2015 CONSISTED OF COSTS TO SUPPORT SCIENTIFIC STUDY AND INVESTIGATIONS. 507 GRANTS WERE AWARDED IN 2015.
4c (Code:   ) (Expenses $   including grants of $   ) (Revenue $   )
4d Other program services (Describe in Schedule O.)
(Expenses $   including grants of $   ) (Revenue $   )
4e Total program service expensesMediumBullet123,080,649
Form 990 (2015)
Form 990 (2015)
Page 3
Part IV
Checklist of Required Schedules
Yes
No
1
Is the organization described in section 501(c)(3) or 4947(a)(1) (other than a private foundation)? If "Yes," complete Schedule AClick to see attachment.....................
1
Yes
 
2
Is the organization required to complete Schedule B, Schedule of Contributors (see instructions)? Click to see attachment...
2
Yes
 
3
Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to candidates for public office? If "Yes," complete Schedule C, Part I.............
3
 
No
4
Section 501(c)(3) organizations. Did the organization engage in lobbying activities, or have a section 501(h) election in effect during the tax year? If "Yes," complete Schedule C, Part II..............
4
 
No
5
Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Revenue Procedure 98-19? If "Yes," complete Schedule C, Part III.................
5
 
No
6
Did the organization maintain any donor advised funds or any similar funds or accounts for which donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If "Yes," complete Schedule D, Part IClick to see attachment..................
6
 
No
7
Did the organization receive or hold a conservation easement, including easements to preserve open space,
the environment, historic land areas, or historic structures? If "Yes," complete Schedule D, Part IIClick to see attachment...
7
 
No
8
Did the organization maintain collections of works of art, historical treasures, or other similar assets? If "Yes," complete Schedule D, Part III Click to see attachment.............
8
 
No
9
Did the organization report an amount in Part X, line 21 for escrow or custodial account liability; serve as a custodian for amounts not listed in Part X; or provide credit counseling, debt management, credit repair, or debt negotiation services? If "Yes," complete Schedule D, Part IVClick to see attachment..............
9
 
No
10
Did the organization, directly or through a related organization, hold assets in temporarily restricted endowments, permanent endowments, or quasi-endowments? If "Yes," complete Schedule D, Part VClick to see attachment......
10
 
No
11
If the organization’s answer to any of the following questions is "Yes," then complete Schedule D, Parts VI, VII, VIII, IX, or X as applicable.
a
Did the organization report an amount for land, buildings, and equipment in Part X, line 10?
If "Yes," complete Schedule D, Part VI.Click to see attachment...................
11a
Yes
 
b
Did the organization report an amount for investments—other securities in Part X, line 12 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIIClick to see attachment.......
11b
 
No
c
Did the organization report an amount for investments—program related in Part X, line 13 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIIIClick to see attachment.......
11c
 
No
d
Did the organization report an amount for other assets in Part X, line 15 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part IXClick to see attachment............
11d
Yes
 
e
Did the organization report an amount for other liabilities in Part X, line 25? If "Yes," complete Schedule D, Part XClick to see attachment
11e
 
No
f
Did the organization’s separate or consolidated financial statements for the tax year include a footnote that addresses the organization’s liability for uncertain tax positions under FIN 48 (ASC 740)? If "Yes," complete Schedule D, Part XClick to see attachment
11f
Yes
 
12a
Did the organization obtain separate, independent audited financial statements for the tax year?
If "Yes," complete Schedule D, Parts XI and XII Click to see attachment.................
12a
 
No
b
Was the organization included in consolidated, independent audited financial statements for the tax year? If "Yes," and if the organization answered "No" to line 12a, then completing Schedule D, Parts XI and XII is optional Click to see attachment
12b
Yes
 
13
Is the organization a school described in section 170(b)(1)(A)(ii)? If "Yes," complete Schedule E
13
 
No
14a
Did the organization maintain an office, employees, or agents outside of the United States? .....
14a
 
No
b
Did the organization have aggregate revenues or expenses of more than $10,000 from grantmaking, fundraising, business, investment, and program service activities outside the United States, or aggregate foreign investments valued at $100,000 or more? If "Yes," complete Schedule F, Parts I and IV.........Click to see attachment
14b
Yes
 
15
Did the organization report on Part IX, column (A), line 3, more than $5,000 of grants or other assistance to or for any foreign organization? If “Yes,” complete Schedule F, Parts II and IV.....Click to see attachment
15
Yes
 
16
Did the organization report on Part IX, column (A), line 3, more than $5,000 of aggregate grants or other assistance to or for foreign individuals? If “Yes,” complete Schedule F, Parts III and IV...Click to see attachment
16
 
No
17
Did the organization report a total of more than $15,000 of expenses for professional fundraising services on Part IX, column (A), lines 6 and 11e? If "Yes," complete Schedule G, Part I (see instructions) ....
17
 
No
18
Did the organization report more than $15,000 total of fundraising event gross income and contributions on Part VIII, lines 1c and 8a? If "Yes," complete Schedule G, Part II............
18
 
No
19
Did the organization report more than $15,000 of gross income from gaming activities on Part VIII, line 9a? If "Yes," complete Schedule G, Part III...................
19
 
No
20a
Did the organization operate one or more hospital facilities? If "Yes," complete Schedule H....
20a
 
No
b
If "Yes" to line 20a, did the organization attach a copy of its audited financial statements to this return?
20b
 
 
Form 990 (2015)
Form 990 (2015)
Page 4
Part IV
Checklist of Required Schedules (continued)
21
Did the organization report more than $5,000 of grants or other assistance to any domestic organization or domestic government on Part IX, column (A), line 1? If “Yes,” complete Schedule I, Parts I and II.....Click to see attachment
21
Yes
 
22
Did the organization report more than $5,000 of grants or other assistance to or for domestic individuals on Part IX, column (A), line 2? If “Yes,” complete Schedule I, Parts I and III........Click to see attachment
22
Yes
 
23
Did the organization answer "Yes" to Part VII, Section A, line 3, 4, or 5 about compensation of the organization’s current and former officers, directors, trustees, key employees, and highest compensated employees? If "Yes," complete Schedule J....................... Click to see attachment
23
Yes
 
24a
Did the organization have a tax-exempt bond issue with an outstanding principal amount of more than $100,000 as of the last day of the year, that was issued after December 31, 2002? If “Yes,” answer lines 24b through 24d and complete Schedule K. If “No,” go to line 25a...............
24a
 
No
b
Did the organization invest any proceeds of tax-exempt bonds beyond a temporary period exception?...
24b
 
 
c
Did the organization maintain an escrow account other than a refunding escrow at any time during the year
to defease any tax-exempt bonds? ...............
24c
 
 
d
Did the organization act as an "on behalf of" issuer for bonds outstanding at any time during the year?...
24d
 
 
25a
Section 501(c)(3), 501(c)(4), and 501(c)(29) organizations. Did the organization engage in an excess benefit transaction with a disqualified person during the year? If "Yes," complete Schedule L, Part I............
25a
 
No
b
Is the organization aware that it engaged in an excess benefit transaction with a disqualified person in a prior year, and that the transaction has not been reported on any of the organization’s prior Forms 990 or 990-EZ? If "Yes," complete Schedule L, Part I ...................
25b
 
No
26
Did the organization report any amount on Part X, line 5, 6, or 22 for receivables from or payables to any current or former officers, directors, trustees, key employees, highest compensated employees, or disqualified persons? If "Yes," complete Schedule L, Part II ................
26
 
No
27
Did the organization provide a grant or other assistance to an officer, director, trustee, key employee, substantial contributor or employee thereof, a grant selection committee member, or to a 35% controlled entity or family member of any of these persons? If "Yes," complete Schedule L, Part III.........
27
 
No
28
Was the organization a party to a business transaction with one of the following parties (see Schedule L, Part IV instructions for applicable filing thresholds, conditions, and exceptions):
a
A current or former officer, director, trustee, or key employee? If "Yes," complete Schedule L,
Part IV ........................
28a
 
No
b
A family member of a current or former officer, director, trustee, or key employee? If "Yes," complete Schedule L, Part IV.....................
28b
 
No
c
An entity of which a current or former officer, director, trustee, or key employee (or a family member thereof) was an officer, director, trustee, or direct or indirect owner? If "Yes," complete Schedule L, Part IV...
28c
 
No
29
Did the organization receive more than $25,000 in non-cash contributions? If "Yes," complete Schedule M..
29
 
No
30
Did the organization receive contributions of art, historical treasures, or other similar assets, or qualified conservation contributions? If "Yes," complete Schedule M .............
30
 
No
31
Did the organization liquidate, terminate, or dissolve and cease operations? If "Yes," complete Schedule N, Part I.
31
 
No
32
Did the organization sell, exchange, dispose of, or transfer more than 25% of its net assets? If "Yes," complete Schedule N, Part II ...........
32
 
No
33
Did the organization own 100% of an entity disregarded as separate from the organization under Regulations sections 301.7701-2 and 301.7701-3? If "Yes," complete Schedule R, Part I ........Click to see attachment
33
 
No
34
Was the organization related to any tax-exempt or taxable entity? If "Yes," complete Schedule R, Part II, III, or IV, and Part V, line 1.........................Click to see attachment
34
Yes
 
35a
Did the organization have a controlled entity within the meaning of section 512(b)(13)?
35a
 
No
b
If ‘Yes’ to line 35a, did the organization receive any payment from or engage in any transaction with a controlled entity within the meaning of section 512(b)(13)? If "Yes," complete Schedule R, Part V, line 2 ...
35b
 
 
36
Section 501(c)(3) organizations. Did the organization make any transfers to an exempt non-charitable related organization? If "Yes," complete Schedule R, Part V, line 2............. Click to see attachment
36
 
No
37
Did the organization conduct more than 5% of its activities through an entity that is not a related organization and that is treated as a partnership for federal income tax purposes? If "Yes," complete Schedule R, Part VIClick to see attachment
37
 
No
38
Did the organization complete Schedule O and provide explanations in Schedule O for Part VI, lines 11b and 19? Note. All Form 990 filers are required to complete Schedule O. ............
38
Yes
 
Form 990 (2015)
Form 990 (2015)
Page 5
Part V
Statements Regarding Other IRS Filings and Tax Compliance
Check if Schedule O contains a response or note to any line in this Part V...........
Yes
No
1a
Enter the number reported in Box 3 of Form 1096 Enter -0- if not applicable ..
1a
97
b
Enter the number of Forms W-2G included in line 1a. Enter -0- if not applicable .
1b
0
c
Did the organization comply with backup withholding rules for reportable payments to vendors and reportable gaming (gambling) winnings to prize winners? ..................
1c
Yes
 
2a
Enter the number of employees reported on Form W-3, Transmittal of Wage and
Tax Statements, filed for the calendar year ending with or within the year covered by this return ..................
2a
39
b
If at least one is reported on line 2a, did the organization file all required federal employment tax returns?
Note. If the sum of lines 1a and 2a is greater than 250, you may be required to e-file (see instructions)
2b
Yes
 
3a
Did the organization have unrelated business gross income of $1,000 or more during the year?...
3a
 
No
b
If “Yes,” has it filed a Form 990-T for this year? If “No” to line 3b, provide an explanation in Schedule O...
3b
 
 
4a
At any time during the calendar year, did the organization have an interest in, or a signature or other authority over, a financial account in a foreign country (such as a bank account, securities account, or other financial account)? ..
4a
 
No
b
If "Yes," enter the name of the foreign country: MediumBullet
See instructions for filing requirements for FinCEN Form 114, Report of Foreign Bank and Financial Accounts (FBAR).
5a
Was the organization a party to a prohibited tax shelter transaction at any time during the tax year? ..
5a
 
No
b
Did any taxable party notify the organization that it was or is a party to a prohibited tax shelter transaction?
5b
 
No
c
If "Yes," to line 5a or 5b, did the organization file Form 8886-T? ............
5c
 
 
6a
Does the organization have annual gross receipts that are normally greater than $100,000, and did the organization solicit any contributions that were not tax deductible as charitable contributions? ...
6a
 
No
b
If "Yes," did the organization include with every solicitation an express statement that such contributions or gifts were not tax deductible? ......................
6b
 
 
7
Organizations that may receive deductible contributions under section 170(c).
a
Did the organization receive a payment in excess of $75 made partly as a contribution and partly for goods and services provided to the payor? ....................
7a
 
No
b
If "Yes," did the organization notify the donor of the value of the goods or services provided? .....
7b
 
 
c
Did the organization sell, exchange, or otherwise dispose of tangible personal property for which it was required to file Form 8282? .........................
7c
 
No
d
If "Yes," indicate the number of Forms 8282 filed during the year ....
7d
 
e
Did the organization receive any funds, directly or indirectly, to pay premiums on a personal benefit contract?
7e
 
No
f
Did the organization, during the year, pay premiums, directly or indirectly, on a personal benefit contract? ..
7f
 
No
g
If the organization received a contribution of qualified intellectual property, did the organization file Form 8899 as required? ......................
7g
 
 
h
If the organization received a contribution of cars, boats, airplanes, or other vehicles, did the organization file a Form 1098-C? ..........................
7h
 
 
8
Sponsoring organizations maintaining donor advised funds.
Did a donor advised fund maintained by the sponsoring organization have excess business holdings at any time during the year? .........................
8
 
 
9a
Did the sponsoring organization make any taxable distributions under section 4966?...
9a
 
 
b
Did the sponsoring organization make a distribution to a donor, donor advisor, or related person?...
9b
 
 
10
Section 501(c)(7) organizations. Enter:
a
Initiation fees and capital contributions included on Part VIII, line 12 ...
10a
 
b
Gross receipts, included on Form 990, Part VIII, line 12, for public use of club facilities
10b
 
11
Section 501(c)(12) organizations. Enter:
a
Gross income from members or shareholders .........
11a
 
b
Gross income from other sources (Do not net amounts due or paid to other sources against amounts due or received from them.) ..........
11b
 
12a
Section 4947(a)(1) non-exempt charitable trusts. Is the organization filing Form 990 in lieu of Form 1041?
12a
 
 
b
If "Yes," enter the amount of tax-exempt interest received or accrued during the year.
12b
 
13
Section 501(c)(29) qualified nonprofit health insurance issuers.
a
Is the organization licensed to issue qualified health plans in more than one state?
Note. See the instructions for additional information the organization must report on Schedule O.
13a
 
 
b
Enter the amount of reserves the organization is required to maintain by the states in which the organization is licensed to issue qualified health plans ....
13b
 
c
Enter the amount of reserves on hand ............
13c
 
14a
Did the organization receive any payments for indoor tanning services during the tax year?.....
14a
 
No
b
If "Yes," has it filed a Form 720 to report these payments? If "No," provide an explanation in Schedule O..
14b
 
 
Form 990 (2015)
Form 990 (2015)
Page 6
Part VI
Governance, Management, and Disclosure For each "Yes" response to lines 2 through 7b below, and for a "No" response to lines 8a, 8b, or 10b below, describe the circumstances, processes, or changes in Schedule O. See instructions.
Check if Schedule O contains a response or note to any line in this Part VI ..............
Section A. Governing Body and Management
Yes
No
1a
Enter the number of voting members of the governing body at the end of the tax year
1a
8
If there are material differences in voting rights among members of the governing body, or if the governing body delegated broad authority to an executive committee or similar committee, explain in Schedule O.
b
Enter the number of voting members included in line 1a, above, who are independent
1b
7
2
Did any officer, director, trustee, or key employee have a family relationship or a business relationship with any other officer, director, trustee, or key employee? .................
2
 
No
3
Did the organization delegate control over management duties customarily performed by or under the direct supervision of officers, directors or trustees, or key employees to a management company or other person? .
3
 
No
4
Did the organization make any significant changes to its governing documents since the prior Form 990 was filed? ...........................
4
 
No
5
Did the organization become aware during the year of a significant diversion of the organization’s assets? .
5
 
No
6
Did the organization have members or stockholders? ................
6
 
No
7a
Did the organization have members, stockholders, or other persons who had the power to elect or appoint one or more members of the governing body? ....................
7a
Yes
 
b
Are any governance decisions of the organization reserved to (or subject to approval by) members, stockholders, or persons other than the governing body? ...................
7b
 
No
8
Did the organization contemporaneously document the meetings held or written actions undertaken during the year by the following:
a
The governing body? .......................
8a
Yes
 
b
Each committee with authority to act on behalf of the governing body? ............
8b
Yes
 
9
Is there any officer, director, trustee, or key employee listed in Part VII, Section A, who cannot be reached at the organization’s mailing address? If "Yes," provide the names and addresses in Schedule O.......
9
 
No
Section B. Policies (This Section B requests information about policies not required by the Internal Revenue Code.)
Yes
No
10a
Did the organization have local chapters, branches, or affiliates? ............
10a
 
No
b
If "Yes," did the organization have written policies and procedures governing the activities of such chapters, affiliates, and branches to ensure their operations are consistent with the organization's exempt purposes?
10b
 
 
11a
Has the organization provided a complete copy of this Form 990 to all members of its governing body before filing the form? ............................
11a
Yes
 
b
Describe in Schedule O the process, if any, used by the organization to review this Form 990. .....
12a
Did the organization have a written conflict of interest policy? If "No," go to line 13.......
12a
Yes
 
b
Were officers, directors, or trustees, and key employees required to disclose annually interests that could give rise to conflicts? ..........................
12b
Yes
 
c
Did the organization regularly and consistently monitor and enforce compliance with the policy? If "Yes," describe in Schedule O how this was done...................
12c
Yes
 
13
Did the organization have a written whistleblower policy? ...............
13
Yes
 
14
Did the organization have a written document retention and destruction policy? .........
14
Yes
 
15
Did the process for determining compensation of the following persons include a review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision?
a
The organization’s CEO, Executive Director, or top management official ...........
15a
Yes
 
b
Other officers or key employees of the organization ................
15b
Yes
 
If "Yes" to line 15a or 15b, describe the process in Schedule O (see instructions).
16a
Did the organization invest in, contribute assets to, or participate in a joint venture or similar arrangement with a taxable entity during the year? ......................
16a
 
No
b
If "Yes," did the organization follow a written policy or procedure requiring the organization to evaluate its participation in joint venture arrangements under applicable federal tax law, and take steps to safeguard the organization’s exempt status with respect to such arrangements? ............
16b
 
 
Section C. Disclosure
17
List the States with which a copy of this Form 990 is required to be filedMediumBullet
MI
18
Section 6104 requires an organization to make its Form 1023 (or 1024 if applicable), 990, and 990-T (501(c)(3)s only) available for public inspection. Indicate how you made these available. Check all that apply.
19
Describe in Schedule O whether (and if so, how) the organization made its governing documents, conflict of interest policy, and financial statements available to the public during the tax year.
20
State the name, address, and telephone number of the person who possesses the organization's books and records:
MediumBulletPRESTON W CAMPBELL MD6931 ARLINGTON RD STE 200   BETHESDA,MD20814 (301) 951-4422
Form 990 (2015)
Form 990 (2015)
Page 7
Part VII
Compensation of Officers, Directors,Trustees, Key Employees, Highest Compensated Employees, and Independent Contractors
Check if Schedule O contains a response or note to any line in this Part VII ..............
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees
1a Complete this table for all persons required to be listed. Report compensation for the calendar year ending with or within the organization’s tax year.
RoundBullet List all of the organization’s current officers, directors, trustees (whether individuals or organizations), regardless of amount
of compensation. Enter -0- in columns (D), (E), and (F) if no compensation was paid.

RoundBullet List all of the organization’s current key employees, if any. See instructions for definition of "key employee."
RoundBullet List the organization’s five current highest compensated employees (other than an officer, director, trustee or key employee)
who received reportable compensation (Box 5 of Form W-2 and/or Box 7 of Form 1099-MISC) of more than $100,000 from the
organization and any related organizations.

RoundBullet List all of the organization’s former officers, key employees, or highest compensated employees who received more than $100,000
of reportable compensation from the organization and any related organizations.

RoundBullet List all of the organization’s former directors or trustees that received, in the capacity as a former director or trustee of the
organization, more than $10,000 of reportable compensation from the organization and any related organizations.

List persons in the following order: individual trustees or directors; institutional trustees; officers; key employees; highest
compensated employees; and former such persons.
Check this box if neither the organization nor any related organization compensated any current officer, director, or trustee.
(A)
Name and Title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(1) JASON M ARYEH......................................................................
DIRECTOR
 3.0
.................
0.0 		X           0 0 0
(2) JONATHAN COHN MD......................................................................
DIRECTOR
 3.0
.................
0.0 		X           0 0 0
(3) CATHERINE C MCLOUD......................................................................
DIRECTOR
 3.0
.................
11.0 		X           0 0 0
(4) D PAUL FLESSNER......................................................................
DIRECTOR
 3.0
.................
0.0 		X           0 0 0
(5) STEVEN SHAK MD......................................................................
DIRECTOR
 3.0
.................
6.0 		X           0 0 0
(6) ERIC R OLSON PHD......................................................................
DIRECTOR
 3.0
.................
0.0 		X           0 0 0
(7) THEODORE J TORPHY PHD......................................................................
CHAIR
 5.0
.................
6.0 		X           13,200 0 0
(8) PRESTON CAMPBELL MD......................................................................
PRESIDENT & CEO (AS OF 10/1)
 20.0
.................
40.0 		X   X       245,571 496,970 212,541
(9) ROBERT BEALL PHD......................................................................
PRESIDENT & CEO (UNTIL 9/30)
 20.0
.................
40.0 		X   X       779,230 1,575,208 108,896
(10) C RICHARD MATTINGLY......................................................................
EXECUTIVE VP & COO
 5.0
.................
55.0 		    X       0 2,718,373 68,546
(11) VERA H TWIGG......................................................................
EXECUTIVE VP, CFO & SECRETARY
 5.0
.................
55.0 		    X       0 499,672 107,968
(12) BRUCE MARSHALL MD......................................................................
SENIOR VP OF CLINICAL AFFAIRS
 35.0
.................
15.0 		        X   314,135 129,754 32,060
(13) MICHAEL P BOYLE MD......................................................................
SENIOR VP OF THERAPEUTICS DEV.
 50.0
.................
0.0 		        X   268,355 0 14,595
(14) CHRIS PENLAND PHD......................................................................
VICE PRESIDENT OF RESEARCH
 23.0
.................
27.0 		        X   122,428 139,512 53,305
(15) WILLIAM SKACH MD......................................................................
SENIOR VP OF RESEARCH AFFAIRS
 38.0
.................
12.0 		        X   233,504 74,887 48,493
(16) DAVID MCLOUGHLIN......................................................................
SR. VP OF OPERATIONS
 35.0
.................
15.0 		        X   108,101 253,478 60,349


Form 990 (2015)
Form 990 (2015)
Page 8
Part VII
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (continued)
(A)
Name and Title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;


























1b Sub-Total................MediumBullet
c Total from continuation sheets to Part VII, Section A....MediumBullet
d Total (add lines 1b and 1c)...........MediumBullet 2,084,524 5,887,854 706,753
2
Total number of individuals (including but not limited to those listed above) who received more than $100,000 of reportable compensation from the organization MediumBullet18
Yes
No
3
Did the organization list any former officer, director or trustee, key employee, or highest compensated employee on line 1a? If "Yes," complete Schedule J for such individual ..............
3
 
No
4
For any individual listed on line 1a, is the sum of reportable compensation and other compensation from the organization and related organizations greater than $150,000? If "Yes," complete Schedule J for such
individual...........................
4
Yes
 
5
Did any person listed on line 1a receive or accrue compensation from any unrelated organization or individual for services rendered to the organization? If "Yes," complete Schedule J for such person ........
5
 
No
Section B. Independent Contractors
1
Complete this table for your five highest compensated independent contractors that received more than $100,000 of compensation from the organization. Report compensation for the calendar year ending with or within the organization’s tax year.
(A)
Name and business address 		(B)
Description of services 		(C)
Compensation
PFIZER INC,
200 CAMBRIDGEPARK DRIVE
CAMBRIDGE,MA02140 		CONTRACTED RESEARCH 13,724,392
GENZYME CORPORATION,
FIVE MOUNTAIN ROAD
FRAMINGHAM,MA01701 		CONTRACTED RESEARCH 5,856,680
SHIRE ORPHAN RARE DISEASE GMBH,
ZAHLERWEG 10
ZUG,0  
SZ 		CONTRACTED RESEARCH 4,987,500
ALGIPHARMA AS,
INDUSTRIVAN 33
SANOVINA,0  
NO 		CONTRACTED RESEARCH 4,800,000
ANTHERA PHARMACEUTICALS,
25801 INDUSTRIAL BLVD
HAYWARD,CA94545 		CONTRACTED RESEARCH 2,638,627
2
Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization MediumBullet26
Form 990 (2015)
Form 990 (2015)
Page 9
Part VIII
Statement of Revenue
Check if Schedule O contains a response or note to any line in this Part VIII .............
(A)
Total revenue 		(B)
Related or
exempt
function
revenue 		(C)
Unrelated
business
revenue 		(D)
Revenue
excluded from
tax under sections
512-514
Contributions, Gifts, GrantAmt and OtherAmt Similar Amounts 1a Federated campaigns..1a  
b Membership dues..1b  
c Fundraising events..1c  
d Related organizations1d 86,230,120
e Government grants (contributions)1e  
f All other contributions, gifts, grants, and similar amounts not included above1f 0
g Noncash contributions included in lines 1a-1f:$  
h Total.Add lines 1a-1f.......MediumBullet 86,230,120
Program Service RevenueAmt Business Code
2a CLINICAL STUDY 541900 120,217 120,217    
b
c
d
e
f All other program service revenue.        
g Total.Add lines 2a–2f.....MediumBullet 120,217
OtherAmt RevenueAmt 3 Investment income (including dividends, interest, and othersimilar amounts) ..........MediumBullet 0      
4 Income from investment of tax-exempt bond proceedsMediumBullet 0      
5 Royalties...........MediumBullet 31,822,208 31,822,208    
(ii) Personal (i) Real
6a Gross rents    
b Less: rental expenses    
c Rental income or (loss) 0 0
d Net rental income or (loss)......MediumBullet 0      
(ii) Other (i) Securities
7a Gross amount from sales of assets other than inventory    
b Less: cost or other basis and sales expenses    
c Gain or (loss)    
d Net gain or (loss).....MediumBullet 0      
8a Gross income from fundraising events (not including $   of contributions reported on line 1c). See Part IV, line 18 ....
a  
b Less: direct expenses ...b  
c Net income or (loss) from fundraising events..MediumBullet 0    
9a Gross income from gaming activities.
See Part IV, line 19 ...
a  
b Less: direct expenses ...b  
c Net income or (loss) from gaming activities..MediumBullet 0      
10a Gross sales of inventory, less
returns and allowances ..
a  
b Less: cost of goods sold ..b  
c Net income or (loss) from sales of inventory..MediumBullet 0      
Business Code Miscellaneous Revenue
11a REFUNDED OR CANCELLED GRANT 900099 5,908,624 5,908,624    
b MISCELLANEOUS INCOME 900099 200,000 200,000    
c            
d All other revenue ....        
e Total. Add lines 11a–11d ...... MediumBullet 6,108,624
12 Total revenue. See Instructions......MediumBullet 124,281,169 38,051,049 0 0
Form 990 (2015)
Form 990 (2015)
Page 10
Part IX
Statement of Functional Expenses
Section 501(c)(3) and 501(c)(4) organizations must complete all columns. All other organizations must complete column (A).Check if Schedule O contains a response or note to any line in this Part IX ..............
Do not include amounts reported on lines 6b,
7b, 8b, 9b, and 10b of Part VIII. 		(A)
Total expenses 		(B)
Program service expenses 		(C)
Management and general expenses 		(D)
Fundraising expenses
1 Grants and other assistance to domestic organizations and domestic governments. See Part IV, line 21 55,715,621 55,715,621
2 Grants and other assistance to individuals in the United States. See Part IV, line 22 7,000 7,000
3 Grants and other assistance to governments, organizations, and individuals outside the United States. See Part IV, lines 15 and 16 6,296,275 6,296,275
4 Benefits paid to or for members 0  
5 Compensation of current officers, directors, trustees, and key employees .... 1,109,667 1,012,768 96,899  
6 Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) .... 0      
7 Other salaries and wages 6,740,789 6,152,165 588,624  
8 Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) .... 268,819 245,345 23,474  
9 Other employee benefits ....... 423,586 386,597 36,989  
10 Payroll taxes ........... 459,332 413,720 45,612  
11 Fees for services (non-employees):        
a Management ...... 0      
b Legal ......... 604,718 604,718    
c Accounting ........... 3,990   3,990  
d Lobbying ........... 0      
e Professional fundraising services. See Part IV, line 17 0  
f Investment management fees ...... 0      
g Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O) 276,438 223,242 53,196  
12 Advertising and promotion .... 0      
13 Office expenses ....... 1,091,426 975,603 115,823  
14 Information technology ...... 882,625 782,729 99,896  
15 Royalties .. 0      
16 Occupancy ........... 1,051,598 995,202 56,396  
17 Travel ............ 274,593 257,848 16,745  
18 Payments of travel or entertainment expenses for any federal, state, or local public officials . 0      
19 Conferences, conventions, and meetings .... 439,323 416,520 22,803  
20 Interest ........... 0      
21 Payments to affiliates ....... 0      
22 Depreciation, depletion, and amortization .. 466,409 450,668 15,741  
23 Insurance ... 324,275 324,275    
24 Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a CONTRACTED RESEARCH 46,960,119 46,960,119    
b MEDICAL ADVISORY FEES 497,387 497,387    
c MISCELLANEOUS 387,179 362,847 24,332  
d
e All other expenses        
25 Total functional expenses. Add lines 1 through 24e 124,281,169 123,080,649 1,200,520 0
26 Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here MediumBullet if following SOP 98-2 (ASC 958-720).        
Form 990 (2015)
Form 990 (2015)
Page 11
Part X
Balance Sheet
Check if Schedule O contains a response or note to any line in this Part IX ..............
(A)
Beginning of year 		(B)
End of year
Assets 1 Cash–non-interest-bearing ........ 0 1 0
2 Savings and temporary cash investments ......... 2,026,003 2 -3,060,639
3 Pledges and grants receivable, net ...... 0 3 0
4 Accounts receivable, net ............. 261,700 4 28,485,525
5 Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L
0 5 0
6 Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L
0 6 0
7 Notes and loans receivable, net .... 0 7 0
8 Inventories for sale or use ........ 0 8 0
9 Prepaid expenses and deferred charges ...... 404,036 9 577,130
10a Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D 10a 2,534,959
b Less: accumulated depreciation 10b 1,137,407 934,327 10c 1,397,552
11 Investments—publicly traded securities . 0 11 0
12 Investments—other securities. See Part IV, line 11 ..... 0 12 0
13 Investments—program-related. See Part IV, line 11 .. 0 13 0
14 Intangible assets ............... 0 14 0
15 Other assets. See Part IV, line 11 ........... 59,426,357 15 58,395,410
16 Total assets. Add lines 1 through 15 (must equal line 34)... 63,052,423 16 85,794,978
Liabilities 17 Accounts payable and accrued expenses ..... 1,129,462 17 2,971,343
18 Grants payable ... 61,922,961 18 82,823,635
19 Deferred revenue ......... 0 19 0
20 Tax-exempt bond liabilities ......... 0 20 0
21 Escrow or custodial account liability. Complete Part IV of Schedule D 0 21 0
22 Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
persons. Complete Part II of Schedule L.. 0 22 0
23 Secured mortgages and notes payable to unrelated third parties .. 0 23 0
24 Unsecured notes and loans payable to unrelated third parties .. 0 24 0
25 Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D 0 25 0
26 Total liabilities. Add lines 17 through 25.. 63,052,423 26 85,794,978
Net Assets or Fund Balance Organizations that follow SFAS 117 (ASC 958), check here MediumBullet and complete lines 27 through 29, and lines 33 and 34.
27 Unrestricted net assets 0 27 0
28 Temporarily restricted net assets ........... 0 28 0
29 Permanently restricted net assets 0 29 0
Organizations that do not follow SFAS 117 (ASC 958), check here MediumBullet and complete lines 30 through 34.
30 Capital stock or trust principal, or current funds .....   30  
31 Paid-in or capital surplus, or land, building or equipment fund ...   31  
32 Retained earnings, endowment, accumulated income, or other funds   32  
33 Total net assets or fund balances ........... 0 33 0
34 Total liabilities and net assets/fund balances ........ 63,052,423 34 85,794,978
Form 990 (2015)
Form 990 (2015)
Page 12
Part XI
Reconcilliation of Net Assets
Check if Schedule O contains a response or note to any line in this Part XI ..............
1
Total revenue (must equal Part VIII, column (A), line 12) ............
1
124,281,169
2
Total expenses (must equal Part IX, column (A), line 25) ............
2
124,281,169
3
Revenue less expenses. Subtract line 2 from line 1 ..............
3
0
4
Net assets or fund balances at beginning of year (must equal Part X, line 33, column (A)) ..
4
0
5
Net unrealized gains (losses) on investments ...............
5
 
6
Donated services and use of facilities .................
6
 
7
Investment expenses .....................
7
 
8
Prior period adjustments .....................
8
 
9
Other changes in net assets or fund balances (explain in Schedule O) ........
9
 
10
Net assets or fund balances at end of year. Combine lines 3 through 9 (must equal Part X, line 33, column (B))
10
0
Part XII
Financial Statements and Reporting
Check if Schedule O contains a response or note to any line in this Part XII .............
Yes
No
1
Accounting method used to prepare the Form 990:  
If the organization changed its method of accounting from a prior year or checked "Other," explain in
Schedule O.
2a
Were the organization’s financial statements compiled or reviewed by an independent accountant?
2a
 
No
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were compiled or reviewed on a separate basis, consolidated basis, or both:
b
Were the organization’s financial statements audited by an independent accountant?
2b
Yes
 
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were audited on a separate basis, consolidated basis, or both:
c
If "Yes," to line 2a or 2b, does the organization have a committee that assumes responsibility for oversight of the audit, review, or compilation of its financial statements and selection of an independent accountant?
2c
Yes
 
If the organization changed either its oversight process or selection process during the tax year, explain in Schedule O.
3a
As a result of a federal award, was the organization required to undergo an audit or audits as set forth in the Single Audit Act and OMB Circular A-133?
3a
 
No
b
If "Yes," did the organization undergo the required audit or audits? If the organization did not undergo the required audit or audits, explain why in Schedule O and describe any steps taken to undergo such audits.
3b
 
 
Form 990 (2015)
Form 990 (2015)
Additional Data


Software ID:  
Software Version:  
Form 990, Special Condition Description:
Special Condition Description
SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service
Public Charity Status and Public Support
Complete if the organization is a section 501(c)(3) organization or a section 4947(a)(1) nonexempt charitable trust.
right arrow Attach to Form 990 or Form 990-EZ.
right arrow Information about Schedule A (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2015
Open to Public
Inspection
Name of the organization
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC
 
Employer identification number

91-2059167
Part I
Reason for Public Charity Status (All organizations must complete this part.) See instructions.
The organization is not a private foundation because it is: (For lines 1 through 11, check only one box.)
1
2
3
4


5
6
7
8
9
10
11
a
b
c
d
e
f
Enter the number of supported organizations .............. 118

g
Provide the following information about the supported organization(s).
(i)Name of supported organization (ii) EIN (iii) Type of organization (described on lines 1- 9 above (see instructions)) (iv) Is the organization listed in your governing document? (v) Amount of monetary support (see instructions) (vi) Amount of other support (see instructions)
Yes No
(A) CYSTIC FIBROSIS FOUNDATION
  		131930701 7 Yes   0 0
(B) ALBANY MEDICAL COLLEGE
  		141338310 2   No 174,236 0
(C) ALL CHILDREN'S HOSPITAL
  		590683252 3   No 242,316 0
(D) ANN AND ROBERT H LURIE CHILDREN'S HOSPITAL OF CHI
  		363357006 7   No 422,279 0
(E) ARIZONA BOARD OF REGENTS UNIVERSITY OF ARIZONA
  		742652689 6   No 674,659 0
(F) ATLANTIC HEALTH SYSTEM
  		521958352 3   No 326,345 0
(G) BAYLOR COLLEGE OF MEDICINE
  		741613878 2   No 446,113 0
(H) BETH ISRAEL MEDICAL CENTER
  		135564934 3   No 268,845 0
(I) BOARD OF REGENTS OF THE UNIVERSITY OF WISCONSIN SY
  		396006492 6   No 718,674 0
(J) BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UN
  		941156365 2   No 555,836 0
(K) CASE WESTERN RESERVE UNIVERSITY
  		341018992 2   No 1,807,928 0
(L) CEDARS-SINAI MEDICAL CENTER
  		951644600 3   No 162,000 0
(M) CHILDREN'S HEALTH CARE
  		411754276 3   No 174,340 0
(N) CHILDREN'S HOSPITAL CORPORATION (BOSTON CHILDREN'S
  		042774441 3   No 961,223 0
(O) CHILDREN'S HOSPITAL MEDICAL CENTER
  		310833936 3   No 1,758,844 0
(P) CHILDREN'S HOSPITAL MEDICAL CENTER OF AKRON
  		340714357 3   No 89,662 0
(Q) CHILDREN'S HOSPITAL LOS ANGELES
  		951690977 3   No 148,296 0
(R) CHILDREN'S MEDICAL CENTER
  		310672132 3   No 158,148 0
(S) CONNECTICUT CHILDREN'S MEDICAL CENTER
  		060646755 3   No 67,669 0
(T) COOK CHILDREN'S MEDICAL CENTER
  		752051646 3   No 270,377 0
(U) DANA-FARBER CANCER INSTITUTE
  		042263040 7   No 162,000 0
(V) PHILADELPHIA HEALTH & EDUCATION CORPORATION
  		232979433 2   No 93,186 0
(W) EMORY UNIVERSITY
  		580566256 2   No 936,561 0
(X) GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTIT
  		581418202 7   No 116,053 0
(Y) GEORGIA INSTITUTE OF TECHNOLOGY
  		586002023 6   No 264,611 0
(Z) KAISER FOUNDATION RESEARCH INSTITUTE
  		941105628 3   No 217,527 0
(AA) LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER
  		726087770 6   No 162,000 0
(AB) MAINE MEDICAL CENTER
  		010238552 3   No 140,292 0
(AC) MEDICAL UNIVERSITY OF SOUTH CAROLINA
  		576000722 6   No 239,349 0
(AD) MEMORIAL CHILDREN'S HOSPITAL
  		953527031 3   No 300,657 0
(AE) MEMORIAL SLOAN KETTERING CANCER CENTER
  		131924236 3   No 54,097 0
(AF) MONMOUTH MEDICAL CENTER FOUNDATION
  		222456079 7   No 72,203 0
(AG) NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
  		742044647 3   No 610,128 0
(AH) NEMOURS CHILDREN'S CLINIC ORLANDO
  		590634433 3   No 127,526 0
(AI) NORTHWESTERN UNIVERSITY
  		362167817 2   No 157,181 0
(AJ) OREGON HEALTH & SCIENCE UNIVERSITY
  		237083114 5   No 738,950 0
(AK) OSF SAINT FRANCIS MEDICAL CENTER
  		370662569 3   No 83,238 0
(AL) PENNSYLVANIA STATE UNIVERSITY
  		246000376 6   No 111,433 0
(AM) PROVIDENCE ALASKA MEDICAL CENTER
  		920016429 3   No 70,040 0
(AN) REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
  		846000555 2   No 1,570,331 0
(AO) THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW
  		141368361 7   No 566,170 0
(AP) RUTGERS THE STATE UNIVERSITY OF NEW JERSEY
  		462354111 6   No 181,062 0
(AQ) SANFORD CHILDRENS SPECIALITY CLINIC
  		460447693 3   No 181,290 0
(AR) SEATTLE CHILDREN'S HOSPITAL
  		910564748 3   No 14,381,231 0
(AS) SETON HEALTHCARE DELL CHILDREN'S
  		741109643 3   No 163,609 0
(AT) SPECTRUM HEALTH FOUNDATION
  		382752328 7   No 156,618 0
(AU) ST LOUIS UNIVERSITY
  		430654872 2   No 168,935 0
(AV) ST LUKE'S REGIONAL MEDICAL CENTER
  		820161600 3   No 101,594 0
(AW) TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER
  		752668014 6   No 164,866 0
(AX) THE CHILDREN'S HOSPITAL OF PHILADELPHIA
  		231352166 3   No 273,763 0
(AY) THE CHILDREN'S MERCY HOSPITAL
  		440605373 3   No 259,627 0
(AZ) THE CURATORS OF THE UNIVERSITY OF MISSOURI
  		436003859 6   No 22,156 0
(BA) THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
  		112673595 4   No 173,140 0
(BB) THE GENERAL HOSPITAL CORPORATION (MASSACHUSETTS GE
  		042697983 3   No 386,448 0
(BC) THE HITCHCOCK FOUNDATION
  		020222139 7   No 332,360 0
(BD) THE JOHNS HOPKINS UNIVERSITY
  		520595110 2   No 2,749,060 0
(BE) THE MEDICAL COLLEGE OF WISCONSIN
  		390806261 2   No 232,145 0
(BF) THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGI
  		546001796 2   No 166,460 0
(BG) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN D
  		956006144 2   No 492,690 0
(BH) THE REGENTS OF THE UNIVERSITY OF MICHIGAN
  		386006309 2   No 887,567 0
(BI) THE REGENTS OF THE UNIVERSITY OF MINNESOTA
  		416007513 6   No 430,425 0
(BJ) THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HO
  		316056230 4   No 532,249 0
(BK) THE SCRIPPS RESEARCH INSTITUTE
  		330435954 4   No 193,350 0
(BL) THE TOLEDO HOSPITAL
  		344428256 3   No 126,510 0
(BM) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF
  		135598093 2   No 615,484 0
(BN) THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
  		636005396 2   No 1,876,851 0
(BO) THE UNIVERSITY OF CHICAGO
  		362177139 2   No 26,061 0
(BP) THE UNIVERSITY OF IOWA
  		426004813 6   No 2,458,340 0
(BQ) THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
  		566001393 2   No 2,063,278 0
(BR) THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT H
  		741761309 6   No 380,000 0
(BS) THE UNIVERSITY OF UTAH
  		876000525 2   No 766,526 0
(BT) THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL C
  		030179440 2   No 297,424 0
(BU) TRUSTEES OF BOSTON UNIVERSITY
  		042103547 2   No 81,000 0
(BV) TRUSTEES OF INDIANA UNIVERSITY
  		356001673 2   No 382,742 0
(BW) TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
  		231352685 2   No 55,102 0
(BX) UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES
  		161238821 9   No 12,636 0
(BY) UNIVERSITY OF ALABAMA IN HUNTSVILLE
  		630520830 2   No 145,126 0
(BZ) UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES
  		716046242 6   No 98,960 0
(CA) UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY
  		311435820 9   No 153,539 0
(CB) UNIVERSITY OF COLORADO HEALTH SCIENCES CENTER
  		846000555 2   No 856,012 0
(CC) UNIVERSITY OF FLORIDA
  		596002052 6   No 243,845 0
(CD) UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
  		043167352 6   No 182,322 0
(CE) UNIVERSITY OF MIAMI
  		590624458 2   No 216,505 0
(CF) UNIVERSITY OF NEBRASKA MEDICAL CENTER
  		470491233 2   No 210,962 0
(CG) UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER
  		736017987 6   No 173,593 0
(CH) UNIVERSITY OF PITTSBURGH
  		250965591 2   No 1,356,500 0
(CI) UNIVERSITY OF ROCHESTER
  		160743209 2   No 278,705 0
(CJ) UNIVERSITY OF SOUTHERN CALIFORNIA
  		951642394 2   No 451,711 0
(CK) UNIVERSITY OF TENNESSEE
  		626001636 6   No 78,027 0
(CL) UNIVERSITY OF WASHINGTON
  		916001537 6   No 554,492 0
(CM) UT SOUTHWESTERN MEDICAL CENTER AT DALLAS
  		756002868 6   No 921,460 0
(CN) VANDERBILT UNIVERSITY
  		620476822 2   No 109,021 0
(CO) VIA CHRISTI REGIONAL MEDICAL CENTER INC
  		481172106 3   No 65,991 0
(CP) VIRGINIA COMMONWEALTH UNIVERSITY
  		546001758 6   No 363,557 0
(CQ) WAKE FOREST UNIVERSITY HEALTH SCIENCES
  		223849199 2   No 61,280 0
(CR) WASHINGTON UNIVERSITY
  		430653611 2   No 354,752 0
(CS) WAYNE STATE UNIVERSITY
  		383028425 2   No 335,704 0
(CT) WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
  		150532082 2   No 162,000 0
(CU) YALE UNIVERSITY
  		060646973 2   No 341,822 0
(CV) AZIENDA OSPEDALIERA UNIVERSITERIA
  		999999999 2   No 60,000 0
(CW) BAR-ILAN UNIVERSITY
  		999999999 2   No 82,998 0
(CX) ERASMUS MC
  		999999999 2   No 901,894 0
(CY) FOUNDATION OF THE FACULTY OF SCIENCES OF THE UNIVERSITY OF L
  		999999999 2   No 277,130 0
(CZ) GOTEBORGS UNIVERSITET CFFT
  		999999999 2   No 116,640 0
(DA) HEBREW UNIVERSITY OF JERUSALEM
  		999999999 2   No 162,000 0
(DB) INSTITUTE OF CHILD HEALTH UNIVERSITY COLLEGE LONDON
  		999999999 2   No 147,828 0
(DC) MCGILL UNIVERSITY
  		999999999 2   No 262,660 0
(DD) QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE
  		999999999 4   No 107,824 0
(DE) ROYAL COLLEGE OF SURGEONS IN IRELAND
  		999999999 2   No 162,000 0
(DF) SIMON FRASER UNIVERSITY
  		999999999 2   No 50,000 0
(DG) ST MICHAEL'S HOSPITAL UNIVERSITY OF TORONTO
  		999999999 2   No 91,319 0
(DH) THE HOSPITAL FOR SICK CHILDREN
  		999999999 3   No 790,714 0
(DI) THE UNIVERSITY OF CAMBRIDGE
  		999999999 2   No 162,000 0
(DJ) THE UNIVERSITY OF WESTERN AUSTRALIA
  		999999999 2   No 2,107,172 0
(DK) UNIVERSITY COLLEGE CORK
  		999999999 2   No 51,247 0
(DL) UNIVERSITY HOSPITAL HEIDELBERG
  		999999999 2   No 79,065 0
(DM) UNIVERSITY OF BRITISH COLUMBIA
  		999999999 2   No 88,938 0
(DN) UNIVERSITY OF MANCHESTER
  		999999999 2   No 247,156 0
(DO) UTRECHT UNIVERSITY
  		999999999 2   No 347,690 0
Total 119 62,006,083 0

For Paperwork Reduction Act Notice, see the Instructions for
Form 990 or 990-EZ.
Cat. No. 11285F
Schedule A (Form 990 or 990-EZ) 2015

Schedule A (Form 990 or 990-EZ) 2015
Page 2
Part II
Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2011 (b) 2012 (c) 2013 (d) 2014 (e) 2015 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any unusual grants.) ....            
2 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.......            
3 The value of services or facilities furnished by a governmental unit to the organization without charge..            
4 Total. Add lines 1 through 3            
5 The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f)..  
6 Public support. Subtract line 5 from line 4.  
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2011 (b) 2012 (c) 2013 (d) 2014 (e) 2015 (f) Total
7 Amounts from line 4..            
8 Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources...            
9 Net income from unrelated business activities, whether or not the business is regularly carried on..            
10 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.)..            
11 Total support. Add lines 7 through 10.  
12
12
 
13
First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization, check this box and stop here........................................right arrow
Section C. Computation of Public Support Percentage
14
14
 
15
15
 
16a
b
17a
b
18
Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow
Schedule A (Form 990 or 990-EZ) 2015

Schedule A (Form 990 or 990-EZ) 2015
Page 3
Part III
Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 9 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2011 (b) 2012 (c) 2013 (d) 2014 (e) 2015 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .            
2 Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose......            
3 Gross receipts from activities that are not an unrelated trade or business under section 513...            
4 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...            
5 The value of services or facilities furnished by a governmental unit to the organization without charge..            
6 Total. Add lines 1 through 5.            
7a Amounts included on lines 1, 2, and 3 received from disqualified persons...            
b Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.            
c Add lines 7a and 7b..            
8 Public support. (Subtract line 7c from line 6.)  
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2011 (b) 2012 (c) 2013 (d) 2014 (e) 2015 (f) Total
9 Amounts from line 6...            
10a Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..            
b Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.            
c Add lines 10a and 10b.            
11 Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.            
12 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) ..            
13 Total support. (Add lines 9, 10c, 11, and 12.)..            
14
Section C. Computation of Public Support Percentage
15
15
 
16
16
 
Section D. Computation of Investment Income Percentage
17
17
 
18
18
 
19a
b
20
Schedule A (Form 990 or 990-EZ) 2015

Schedule A (Form 990 or 990-EZ) 2015
Page 4
Part IV
Supporting Organizations
(Complete only if you checked a box on line 11 of Part I. If you checked 11a of Part I, complete Sections A and B. If you checked 11b of Part I, complete Sections A and C. If you checked 11c of Part I, complete Sections A, D, and E. If you checked 11d of Part I, complete Sections A and D, and complete Part V.)
Section A. All Supporting Organizations
Yes
No
1
Are all of the organization’s supported organizations listed by name in the organization’s governing documents?
If "No," describe in Part VI how the supported organizations are designated. If designated by class or purpose,
describe the designation. If historic and continuing relationship, explain.
1
 
No
2
Did the organization have any supported organization that does not have an IRS determination of status under section 509(a)(1) or (2)? If "Yes," explain in Part VI how the organization determined that the supported organization was described in section 509(a)(1) or (2).
2
Yes
 
3a
Did the organization have a supported organization described in section 501(c)(4), (5), or (6)? If "Yes," answer (b) and (c) below.
3a
 
No
b
Did the organization confirm that each supported organization qualified under section 501(c)(4), (5), or (6) and satisfied the public support tests under section 509(a)(2)? If "Yes," describe in Part VI when and how the organization made the determination.
3b
 
 
c
Did the organization ensure that all support to such organizations was used exclusively for section 170(c)(2)(B) purposes? If "Yes," explain in Part VI what controls the organization put in place to ensure such use.
3c
 
 
4a
Was any supported organization not organized in the United States ("foreign supported organization")? If “Yes” and if you checked 11a or 11b in Part I, answer (b) and (c) below.
4a
Yes
 
b
Did the organization have ultimate control and discretion in deciding whether to make grants to the foreign supported organization? If “Yes,” describe in Part VI how the organization had such control and discretion despite being controlled or supervised by or in connection with its supported organizations.
4b
 
No
c
Did the organization support any foreign supported organization that does not have an IRS determination under sections 501(c)(3) and 509(a)(1) or (2)? If “Yes,” explain in Part VI what controls the organization used to ensure that all support to the foreign supported organization was used exclusively for section 170(c)(2)(B) purposes.
4c
Yes
 
5a
Did the organization add, substitute, or remove any supported organizations during the tax year? If “Yes,” answer (b) and (c) below (if applicable). Also, provide detail in Part VI, including (i) the names and EIN numbers of the supported organizations added, substituted, or removed; (ii) the reasons for each such action; (iii) the authority under the organization's organizing document authorizing such action; and (iv) how the action was accomplished (such as by amendment to the organizing document).
5a
 
No
b
Type I or Type II only. Was any added or substituted supported organization part of a class already designated in the organization's organizing document?
5b
 
No
c
Substitutions only. Was the substitution the result of an event beyond the organization's control?
5c
 
 
6
Did the organization provide support (whether in the form of grants or the provision of services or facilities) to anyone other than (i) its supported organizations, (ii) individuals that are part of the charitable class benefited by one or more of its supported organizations, or (iii) other supporting organizations that also support or benefit one or more of the filing organization’s supported organizations? If “Yes,” provide detail in Part VI.
6
 
No
7
Did the organization provide a grant, loan, compensation, or other similar payment to a substantial contributor (defined in section 4958(c)(3)(C)), a family member of a substantial contributor, or a 35% controlled entity with regard to a substantial contributor? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ) .
7
 
No
8
Did the organization make a loan to a disqualified person (as defined in section 4958) not described in line 7? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ).
8
 
No
9a
Was the organization controlled directly or indirectly at any time during the tax year by one or more disqualified persons as defined in section 4946 (other than foundation managers and organizations described in section 509(a)(1) or (2))? If “Yes,” provide detail in Part VI.
9a
 
No
b
Did one or more disqualified persons (as defined in line 9a) hold a controlling interest in any entity in which the supporting organization had an interest? If “Yes,” provide detail in Part VI.
9b
 
No
c
Did a disqualified person (as defined in line 9a) have an ownership interest in, or derive any personal benefit from, assets in which the supporting organization also had an interest? If “Yes,” provide detail in Part VI.
9c
 
No
10a
Was the organization subject to the excess business holdings rules of section 4943 because of section 4943(f) (regarding certain Type II supporting organizations, and all Type III non-functionally integrated supporting organizations)? If “Yes,” answer line 10b below.
10a
 
No
b
Did the organization have any excess business holdings in the tax year? (Use Schedule C, Form 4720, to determine whether the organization had excess business holdings).
10b
 
 
Schedule A (Form 990 or 990-EZ) 2015

Schedule A (Form 990 or 990-EZ) 2015
Page 5
Part IV
Supporting Organizations (continued)
Yes
No
11
Has the organization accepted a gift or contribution from any of the following persons?
a
A person who directly or indirectly controls, either alone or together with persons described in (b) and (c) below, the governing body of a supported organization?
11a
 
No
b
A family member of a person described in (a) above?
11b
 
No
c
A 35% controlled entity of a person described in (a) or (b) above? If “Yes” to a, b, or c, provide detail in Part VI.
11c
 
No
Section B. Type I Supporting Organizations
Yes
No
1
Did the directors, trustees, or membership of one or more supported organizations have the power to regularly appoint or elect at least a majority of the organization’s directors or trustees at all times during the tax year? If “No,” describe in Part VI how the supported organization(s) effectively operated, supervised, or controlled the organization’s activities. If the organization had more than one supported organization, describe how the powers to appoint and/or remove directors or trustees were allocated among the supported organizations and what conditions or restrictions, if any, applied to such powers during the tax year.
1
Yes
 
2
Did the organization operate for the benefit of any supported organization other than the supported organization(s) that operated, supervised, or controlled the supporting organization? If “Yes,” explain in Part VI how providing such benefit carried out the purposes of the supported organization(s) that operated, supervised or controlled the supporting organization.
2
Yes
 
Section C. Type II Supporting Organizations
Yes
No
1
Were a majority of the organization’s directors or trustees during the tax year also a majority of the directors or trustees of each of the organization’s supported organization(s)? If “No,” describe in Part VI how control or management of the supporting organization was vested in the same persons that controlled or managed the supported organization(s).
1
 
 
Section D. All Type III Supporting Organizations
Yes
No
1
Did the organization provide to each of its supported organizations, by the last day of the fifth month of the organization’s tax year, (i) a written notice describing the type and amount of support provided during the prior tax year, (ii) a copy of the Form 990 that was most recently filed as of the date of notification, and (iii) copies of the organization’s governing documents in effect on the date of notification, to the extent not previously provided?
1
 
 
2
Were any of the organization’s officers, directors, or trustees either (i) appointed or elected by the supported organization(s) or (ii) serving on the governing body of a supported organization? If "No," explain in Part VI how the organization maintained a close and continuous working relationship with the supported organization(s).
2
 
 
3
By reason of the relationship described in (2), did the organization’s supported organizations have a significant voice in the organization’s investment policies and in directing the use of the organization’s income or assets at all times during the tax year? If "Yes," describe in Part VI the role the organization’s supported organizations played in this regard.
3
 
 
Section E. Type III Functionally-Integrated Supporting Organizations
1
Check the box next to the method that the organization used to satisfy the Integral Part Test during the year (see instructions):
a
b
c
2
Activities Test. Answer (a) and (b) below.
Yes
No
a
Did substantially all of the organization’s activities during the tax year directly further the exempt purposes of the supported organization(s) to which the organization was responsive? If "Yes," then in Part VI identify those supported organizations and explain how these activities directly furthered their exempt purposes, how the organization was responsive to those supported organizations, and how the organization determined that these activities constituted substantially all of its activities.
2a
 
 
b
Did the activities described in (a) constitute activities that, but for the organization’s involvement, one or more of the organization’s supported organization(s) would have been engaged in? If "Yes," explain in Part VI the reasons for the organization’s position that its supported organization(s) would have engaged in these activities but for the organization’s involvement.
2b
 
 
3
Parent of Supported Organizations. Answer (a) and (b) below.
a
Did the organization have the power to regularly appoint or elect a majority of the officers, directors, or trustees of each of the supported organizations? Provide details in Part VI.
3a
 
 
b
Did the organization exercise a substantial degree of direction over the policies, programs and activities of each of its supported organizations? If "Yes," describe in Part VI. the role played by the organization in this regard.
3b
 
 
Schedule A (Form 990 or 990-EZ) 2015

Schedule A (Form 990 or 990-EZ) 2015
Page 6
Part V
Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations
1
Section A - Adjusted Net Income (A) Prior Year (B) Current Year
(optional)
1 Net short-term capital gain 1    
2 Recoveries of prior-year distributions 2    
3 Other gross income (see instructions) 3    
4 Add lines 1 through 3 4    
5 Depreciation and depletion 5    
6 Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) 6    
7 Other expenses (see instructions) 7    
8 Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) 8    

Section B - Minimum Asset Amount (A) Prior Year (B) Current Year
(optional)
1 Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): 1
a Average monthly value of securities 1a    
b Average monthly cash balances 1b    
c Fair market value of other non-exempt-use assets 1c    
d Total (add lines 1a, 1b, and 1c) 1d    
e Discount claimed for blockage or other factors
(explain in detail in Part VI):  
2 Acquisition indebtedness applicable to non-exempt use assets 2    
3 Subtract line 2 from line 1d 3    
4 Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). 4    
5 Net value of non-exempt-use assets (subtract line 4 from line 3) 5    
6 Multiply line 5 by .035 6    
7 Recoveries of prior-year distributions 7    
8 Minimum Asset Amount (add line 7 to line 6) 8    

Section C - Distributable Amount Current Year
1 Adjusted net income for prior year (from Section A, line 8, Column A) 1  
2 Enter 85% of line 1 2  
3 Minimum asset amount for prior year (from Section B, line 8, Column A) 3  
4 Enter greater of line 2 or line 3 4  
5 Income tax imposed in prior year 5  
6 Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) 6  
7
Schedule A (Form 990 or 990-EZ) 2015

Schedule A (Form 990 or 990-EZ) 2015
Page 7
Part V
Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations (continued)
Section D - Distributions Current Year
1 Amounts paid to supported organizations to accomplish exempt purposes  
2 Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in
excess of income from activity		  
3 Administrative expenses paid to accomplish exempt purposes of supported organizations  
4 Amounts paid to acquire exempt-use assets  
5 Qualified set-aside amounts (prior IRS approval required)  
6 Other distributions (describe in Part VI). See instructions  
7Total annual distributions. Add lines 1 through 6.  
8 Distributions to attentive supported organizations to which the organization is responsive (provide
details in Part VI). See instructions		  
9 Distributable amount for 2015 from Section C, line 6  
10 Line 8 amount divided by Line 9 amount  

Section E - Distribution Allocations (see instructions) (i)
Excess Distributions 		(ii)
Underdistributions
Pre-2015 		(iii)
Distributable
Amount for 2015
1 Distributable amount for 2015 from Section C, line
6 		 
2 Underdistributions, if any, for years prior to 2015
(reasonable cause required--see instructions)		  
3 Excess distributions carryover, if any, to 2015:
a
b
c
d From 2013.......  
e From 2014.......  
fTotal of lines 3a through e  
g Applied to underdistributions of prior years  
h Applied to 2015 distributable amount  
i Carryover from 2010 not applied (see
instructions)
j Remainder. Subtract lines 3g, 3h, and 3i from 3f.  
4Distributions for 2015 from Section D, line 7:
$  
a Applied to underdistributions of prior years  
b Applied to 2015 distributable amount  
c Remainder. Subtract lines 4a and 4b from 4.  
5 Remaining underdistributions for years prior to
2015, if any. Subtract lines 3g and 4a from line 2
(if amount greater than zero, see instructions)		  
6 Remaining underdistributions for 2015. Subtract
lines 3h and 4b from line 1 (if amount greater than
zero, see instructions)		  
7 Excess distributions carryover to 2016. Add lines
3j and 4c.		  
8 Breakdown of line 7:
a
b
c Excess from 2013.......  
d From 2014.......  
e From 2015.......  
Schedule A (Form 990 or 990-EZ) (2015)

Schedule A (Form 990 or 990-EZ) 2015
Page 8
Part VI
Supplemental Information. Provide the explanations required by Part II, line 10; Part II, line 17a or 17b; Part III, line 12; Part IV, Section A, lines 1, 2, 3b, 3c, 4b, 4c, 5a, 6, 9a, 9b, 9c, 11a, 11b, and 11c; Part IV, Section B, lines 1 and 2; Part IV, Section C, line 1; Part IV, Section D, lines 2 and 3; Part IV, Section E, lines 1c, 2a, 2b, 3a and 3b; Part V, line 1; Part V, Section B, line 1e; Part V Section D, lines 5, 6, and 8; and Part V, Section E, lines 2, 5, and 6. Also complete this part for any additional information. (See instructions).
Facts And Circumstances Test
 
Return Reference Explanation
SUPPORTED ORGANIZATIONS SCHEDULE A, PART I, LINE 11G All support provided by Cystic Fibrosis Foundation Therapeutics and reported in column (v) is for the benefit of Cystic Fibrosis Foundation, its supported organization. The support provided to the organizations listed in column (i) funds research critical to furthering the mission of the Cystic Fibrosis Foundation. SCHEDULE A, PART IV, LINE 1 CYSTIC FIBROSIS FOUNDATION IS THE ONLY SUPPORTED ORGANIZATION LISTED BY NAME IN THE GOVERNING DOCUMENTS OF CFFT. ALL OTHER SUPPORTED ORGANIZATIONS ARE DESIGNATED BY THE PURPOSE FOR WHICH THEY APPLY FOR SUPPORT FROM CFFT. ALL SUPPORT IS GIVEN FOR THE PURPOSE OF FUNDING RESEARCH INTO DRUG DEVELOPMENT FOR THE TREATMENT AND CURE OF CYSTIC FIBROSIS. CONTINUED SUPPORT TO ALL ORGANIZATIONS NOT NAMED IN THE GOVERNING DOCUMENTS IS CONTINGENT UPON THE ORGANIZATION DEMONSTRATING SCIENTIFIC PROGRESS. SCHEDULE A, PART IV, LINE 2 SUPPORTED ORGANIZATIONS WHO HAVE NOT RECEIVED AN IRS DETERMINATION LETTER ARE EITHER STATE GOVERNMENTAL UNITS DESCRIBED IN SECTION 170(B)(1)(a)(V) AND TAX EXEMPT UNDER IRC 115 OR ORGANIZATIONS OUTSIDE OF THE U.S. CFFT RECEIVES FROM ALL AWARD RECIPIENTS A W-8 OR W-9 AND A LETTER CERTIFYING THEIR STATUS AS A PUBLICALLY SUPPORTED ORGANIZATION EQUIVALENT TO 509(a)(1) OR 509(a)(2) EITHER WITHIN THE U.S. OR THEIR COUNTRY. SCHEDULE A, PART IV, LINE 4B CYSTIC FIBROSIS FOUNDATION, A SUPPORTED ORGANIZATION, HAD ULTIMATE CONTROL AND DISCRECTION IN DECIDING TO MAKE GRANTS TO FOREIGN SUPPORTED ORGANIZATIONS. SCHEDULE A, PART IV, LINE 4C CFFT RECEIVES FROM ALL FOREIGN SUPPORTED ORGANIZATIONS A W-8 AND A LETTER CERTIFYING THEIR STATUS AS A PUBLICALLY SUPPORTED ORGANIZATION EQUIVALENT TO 509(a)(1) OR 509(a)(2) WITHIN THEIR COUNTRY. FOR THE FULL MONITORING PROCESS OF AWARDS MADE TO FOREIGN SUPPORTED ORGANIZATIONS SEE SCHEDULE F, PART V. SCHEDULE A, PART IV, SECTION B, LINE 2 SEE NARRATIVE FOR SCHEDULE A, PART I, LINE 11G ABOVE.
Schedule A (Form 990 or 990-EZ) 2015


Additional Data


Software ID:  
Software Version:  
Schedule B
(Form 990, 990-EZ,
or 990-PF)
Department of the Treasury
Internal Revenue Service
Schedule of Contributors
Arrow Bullet Attach to Form 990, 990-EZ, or 990-PF.
Arrow Bullet Information about Schedule B (Form 990, 990-EZ, or 990-PF) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2015
Name of the organization
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC
 
Employer identification number

91-2059167
Organization type (check one):
Filers of:
Section:
Form 990 or 990-EZ





Form 990-PF




Check if your organization is covered by the General Rule or a Special Rule.  
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.
General Rule
Special Rules
......... Arrow Bullet $  
Caution. An organization that is not covered by the General Rule and/or the Special Rules does not file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its
Form 990-EZ or on its Form 990PF, Part I, line 2, to certify that it does not meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).
For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.
Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2015)
Schedule B (Form 990, 990-EZ, or 990-PF) (2015) Page 2
Name of organization
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC
  		Employer identification number
91-2059167
Part I
Contributors (see instructions). Use duplicate copies of Part I if additional space is needed.
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
RESTRICTED
 
 

   
 
 
  ,    

$ RESTRICTED


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2015)
Schedule B (Form 990, 990-EZ, or 990-PF) (2015)
Page 3
Name of organization
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC
  		Employer identification number

91-2059167
Part II
Noncash Property (see instructions). Use duplicate copies of Part II if additional space is needed.
(a)
No.from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a)
No.from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a)
No.from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a)
No.from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a)
No.from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a)
No.from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
Schedule B (Form 990, 990-EZ, or 990-PF) (2015)
Schedule B (Form 990, 990-EZ, or 990-PF) (2015)
Page 4
Name of organization
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC
  		Employer identification number

91-2059167
Part III
Exclusively religious, charitable, etc., contributions to organizations described in section 501(c)(7), (8), or (10) that total more than $1,000 for the year from any one contributor. Complete columns (a) through (e) and the following line entry. For organizations completing Part III, enter the total of exclusively religious, charitable, etc., contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet$  
Use duplicate copies of Part III if additional space is needed.
(a)
No.from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No.from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No.from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No.from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
Schedule B (Form 990, 990-EZ, or 990-PF) (2015)

Additional Data


Software ID:  
Software Version:  
SCHEDULE D
(Form 990)
Department of the Treasury
Internal Revenue Service
Supplemental Financial Statements
SchDMd Bullet Complete if the organization answered "Yes," on Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b.
SchDMd Bullet Attach to Form 990.
Information about Schedule D (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2015
Open to Public Inspection
Name of the organization
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC
 
Employer identification number

91-2059167
Part I
Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" on Form 990, Part IV, line 6.
(a) Donor advised funds (b) Funds and other accounts
1 Total number at end of year ....    
2 Aggregate value of contributions to (during year)    
3 Aggregate value of grants from (during year)    
4 Aggregate value at end of year ....    
5
Did the organization inform all donors and donor advisors in writing that the assets held in donor advised
funds are the organization's property, subject to the organization's exclusive legal control? ...........
6
Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be
used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ............................
Part II
Conservation Easements. Complete if the organization answered "Yes" on Form 990, Part IV, line 7.
1
Purpose(s) of conservation easements held by the organization (check all that apply).
2
Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.
Held at the End of the Year
a Total number of conservation easements ...................... 2a  
b Total acreage restricted by conservation easements .................... 2b  
c Number of conservation easements on a certified historic structure included in (a) ..... 2c  
d Number of conservation easements included in (c) acquired after 8/17/06, and not on a historic structure listed in the National Register ... 2d  
3
Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during the
tax year SchDMd Bullet  
4
Number of states where property subject to conservation easement is located SchDMd Bullet  
5
Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and enforcement of the conservation easements it holds? ............
6
Staff and volunteer hours devoted to monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet  
7
Amount of expenses incurred in monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet $  
8
Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .............................
9
In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" on Form 990, Part IV, line 8.
1a
If the organization elected, as permitted under SFAS 116 (ASC 958), not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.
b
If the organization elected, as permitted under SFAS 116 (ASC 958), to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:
(i)
Revenue included on Form 990, Part VIII, line 1 .........................SchDMd Bullet $  
(ii)
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
2
If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 (ASC 958) relating to these items:
a
Revenue included on Form 990, Part VIII, line 1 ..........................SchDMd Bullet $  
b
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 52283D
Schedule D (Form 990) 2015

Schedule D (Form 990) 2015
Page 2
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)
3
Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):
a
d
b
e
 
c
4
Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.
5
During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?...
Part IV
Escrow and Custodial Arrangements. Complete if the organization answered "Yes" on Form 990, Part IV, line 9, or reported an amount on Form 990, Part X, line 21.
1a
Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................
b If "Yes," explain the arrangement in Part XIII and complete the following table: Amount
c Beginning balance ............................. 1c  
d Additions during the year ............................ 1d  
e Distributions during the year .......................... 1e  
f Ending balance ................................ 1f  
2a
Did the organization include an amount on Form 990, Part X, line 21, for escrow or custodial account liability?
b
If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ........
Part V
Endowment Funds. Complete if the organization answered "Yes" on Form 990, Part IV, line 10.
(a)Current year (b)Prior year (c)Two years back (d)Three years back (e)Four years back
1a Beginning of year balance ....          
b Contributions ...          
c Net investment earnings, gains, and losses          
d Grants or scholarships ...          
e Other expenditures for facilities
and programs ... 		         
f Administrative expenses ....          
g End of year balance ......          
2
Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:
a
Board designated or quasi-endowment SchDMd Bullet  
b
Permanent endowment SchDMd Bullet  
c
Temporarily restricted endowment SchDMd Bullet  
The percentages on lines 2a, 2b, and 2c should equal 100%.
3a
Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes
No
(i) unrelated organizations .................
3a(i)
 
 
(ii) related organizations .................
3a(ii)
 
 
b
If "Yes" on 3a(ii), are the related organizations listed as required on Schedule R? .........
3b
 
 
4
Describe in Part XIII the intended uses of the organization's endowment funds.
Part VI
Land, Buildings, and Equipment.
Complete if the organization answered 'Yes' on Form 990, Part IV, line 11a. See Form 990, Part X, line 10.
Description of property (a) Cost or other basis
(investment) 		(b)Cost or other basis (other) (c) Accumulated depreciation (d) Book value
1a Land ...      
b Buildings        
c Leasehold improvements   4,914 4,914 0
d Equipment ...   2,530,045 132,493 1,397,552
e Other ...        
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).)..SchDMdBullet 1,397,552
Schedule D (Form 990) 2015

Schedule D (Form 990) 2015
Page 3
Part VII
Investments—Other Securities. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11b. See Form 990, Part X, line 12.
(a) Description of security or category
(including name of security)		 (b)Book value (c)Method of valuation:
Cost or end-of-year market value
(1)Financial derivatives    
(2)Closely-held equity interests    
(3)Other
(A)
(B)
(C)
(D)
(E)
(F)
(G)
(H)
Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)Small Bullet  
Part VIII
Investments—Program Related. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11c. See Form 990, Part X, line 13.
(a) Description of investment (b) Book value (c) Method of valuation:
Cost or end-of-year market value
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)Small Bullet  
Part IX
Other Assets. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11d. See Form 990, Part X, line 15.
(a) Description (b) Book value
(1) INTERCOMPANY RECEIVABLE 58,395,410
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........Small Bullet 58,395,410
Part X
Other Liabilities. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.
1.(a) Description of liability (b) Book value
(1) Federal income taxes 0
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)Small Bullet 0
2. Liability for uncertain tax positions. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII
Schedule D (Form 990) 2015

Schedule D (Form 990) 2015
Page 4
Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1 Total revenue, gains, and other support per audited financial statements ....... 1  
2 Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a Net unrealized gains (losses) on investments .... 2a  
b Donated services and use of facilities ......... 2b  
c Recoveries of prior year grants ........... 2c  
d Other (Describe in Part XIII.) ............ 2d  
e Add lines 2a through 2d ..................... 2e  
3 Subtract line 2e from line 1.................. 3  
4 Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b . 4a  
b Other (Describe in Part XIII.) ........... 4b  
c Add lines 4a and 4b.................... 4c  
5 Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ...... 5  
Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1 Total expenses and losses per audited financial statements ........... 1  
2 Amounts included on line 1 but not on Form 990, Part IX, line 25:
a Donated services and use of facilities ......... 2a  
b Prior year adjustments ............ 2b  
c Other losses ................ 2c  
d Other (Describe in Part XIII.) ............ 2d  
e Add lines 2a through 2d.................... 2e  
3 Subtract line 2e from line 1................... 3  
4 Amounts included on Form 990, Part IX, line 25, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b .. 4a  
b Other (Describe in Part XIII.) ............ 4b  
c Add lines 4a and 4b..................... 4c  
5 Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ...... 5  

Part XIII
Supplemental Information
Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b;
Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.
Return Reference Explanation
SCHEDULE D, PART X FIN 48 FOOTNOTE THE FOUNDATION, CFFT, AND CFPAF ARE NOT-FOR-PROFIT VOLUNTARY HEALTH ORGANIZATIONS EXEMPT FROM FEDERAL INCOME TAXES UNDER 501(C)(3) OF THE INTERNAL REVENUE CODE (THE CODE) AND FROM STATE TAXES AND HAVE BEEN CLASSIFIED AS ORGANIZATIONS THAT ARE NOT PRIVATE FOUNDATIONS UNDER SECTION 509(A) OF THE CODE. THE FOUNDATION DOES NOT HAVE ANY UNRELATED BUSINESS INCOME TAX LIABILITY AS OF DECEMBER 31, 2015 AND 2014. CONTRIBUTIONS TO THE FOUNDATION QUALIFY FOR THE CHARITABLE CONTRIBUTIONS DEDUCTION TO THE EXTENT PROVIDED BY SECTION 170 OF THE CODE. CFPAF IS ORGANIZED AS A SINGLE MEMBER LIMITED LIABILITY COMPANY THAT IS A DISREGARDED ENTITY FOR FEDERAL TAX PURPOSES. THE SOLE MEMBER OF CFPAF IS THE FOUNDATION. THE FOUNDATION IS NOT AWARE OF ANY TAX POSITION TAKEN THAT REQUIRES DISCLOSURE BASED ON CURRENT FACTS AND CIRCUMSTANCES. THE FOUNDATION ANNUALLY REVIEWS ITS TAX POSITIONS AND HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS.
Schedule D (Form 990) 2015


Additional Data


Software ID:  
Software Version:  




SCHEDULE F(Form 990)
Department of the Treasury
Internal Revenue Service
Statement of Activities Outside the United States
Right pointing arrow large image Complete if the organization answered "Yes" to Form 990,Part IV, line 14b, 15, or 16.Right pointing arrow large image Attach to Form 990. Right pointing arrow large image See separate instructions.Right pointing arrow large image Information about Schedule F (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2015
Open to Public Inspection
Name of the organization
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC
 
Employer identification number

91-2059167
Part I
General Information on Activities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 14b.
1
For grantmakers.Does the organization maintain records to substantiate the amount of its grants and
other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used
to award the grants or assistance? . . . . . . . . . . . . . . . . . . . . . . . . .
2
For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.
3
Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)
(a) Region (b) Number of offices in the region (c) Number of employees, agents, and independent contractors in region (d) Activities conducted in region (by type) (e.g., fundraising, program services, investments, grants to recipients located in the region) (e) If activity listed in (d) is a program service, describe specific type of
service(s) in region		 (f) Total expenditures
for and investments
in region
North America     Grantmaking NONE 1,283,631
Europe (Including Iceland and Greenland)     Grantmaking NONE 2,660,474
East Asia and the Pacific     Grantmaking NONE 2,107,172
Middle East and North Africa     Grantmaking NONE 244,998
Europe (Including Iceland and Greenland)     Program Services CONTRACTED RESEARCH 11,775,000
           
           
           
           
           
           
           
           
           
           
           
           
3a Sub-total .....     18,071,275
b Total from continuation sheets to Part I ...      
c Totals (add lines 3a and 3b)     18,071,275
For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2015
Schedule F (Form 990) 2015
Page 2
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.
1 (a) Name of organization (b) IRS code section
and EIN (if applicable)		 (a)(c) Region (b)(d) Purpose of
grant 		(e) Amount of
cash grant 		(f) Manner of
cash
disbursement 		(g) Amount
of non-cash
assistance 		(h) Description
of non-cash
assistance 		(i) Method of
valuation
(book, FMV,
appraisal, other)
North America CLINICAL RESEARCH 91,319 CHECK      
North America CLINICAL RESEARCH 107,509 CHECK      
North America CLINICAL RESEARCH 25,914 CHECK      
North America DRUG DISCOVERY 262,660 CHECK      
North America DRUG DISCOVERY 657,291 CHECK      
North America DRUG DISCOVERY 50,000 CHECK      
North America DRUG DISCOVERY 88,938 CHECK      
Europe (Including Iceland and Greenland) DRUG DISCOVERY 277,130 WIRE      
Europe (Including Iceland and Greenland) DRUG DISCOVERY 347,690 WIRE      
Europe (Including Iceland and Greenland) DRUG DISCOVERY 195,806 WIRE      
Europe (Including Iceland and Greenland) DRUG DISCOVERY 162,000 WIRE      
Europe (Including Iceland and Greenland) DRUG DISCOVERY 79,065 WIRE      
Europe (Including Iceland and Greenland) DRUG DISCOVERY 116,640 WIRE      
Europe (Including Iceland and Greenland) DRUG DISCOVERY 51,247 WIRE      
Europe (Including Iceland and Greenland) DRUG DISCOVERY 147,828 WIRE      
Europe (Including Iceland and Greenland) DRUG DISCOVERY 51,350 WIRE      
Europe (Including Iceland and Greenland) DRUG DISCOVERY 162,000 WIRE      
Europe (Including Iceland and Greenland) CLINICAL RESEARCH 779,190 WIRE      
Europe (Including Iceland and Greenland) CLINICAL RESEARCH 60,000 WIRE      
Europe (Including Iceland and Greenland) DRUG DISCOVERY 107,824 WIRE      
Europe (Including Iceland and Greenland) CLINICAL RESEARCH 122,704 WIRE      
East Asia and the Pacific DRUG DISCOVERY 162,000 WIRE      
East Asia and the Pacific CLINICAL RESEARCH 1,321,044 WIRE      
East Asia and the Pacific CLINICAL RESEARCH 624,128 WIRE      
Middle East and North Africa DRUG DISCOVERY 162,000 WIRE      
Middle East and North Africa DRUG DISCOVERY 82,998 WIRE      
2 Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .......MediumBullet
20
3 Enter total number of other organizations or entities .......................MediumBullet
 
Schedule F (Form 990) 2015
Schedule F (Form 990) 2015Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 16.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Region (c) Number of recipients (d) Amount of
cash grant 		(e) Manner of cash
disbursement 		(f) Amount of
non-cash
assistance 		(g) Description
of non-cash
assistance 		(h) Method of
valuation
(book, FMV,
appraisal, other)
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
Schedule F (Form 990) 2015
Schedule F (Form 990) 2015
Page 4
Part IV
Foreign Forms
1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes,"the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to separately file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3 Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471). . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621) .
5 Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships. (see Instructions for Form 8865). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6 Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to separately file Form 5713, International Boycott Report (see Instructions for Form 5713).. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Schedule F (Form 990) 2015
Schedule F (Form 990) 2015
Page 5
Part V
Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information (see instructions).
ReturnReference Explanation
PROCEDURES FOR MONITORING GRANT FUNDS OUTSIDE OF THE U.S. SCHEDULE F, PART I, LINE 2 THE ORGANIZATION HAS PROCEDURES IN PLACE TO MONITOR THE SCIENTIFIC PROGRESS AND FINANCIAL ASPECTS OF GRANTS AWARDED TO ENTITIES OUTSIDE OF THE UNITED STATES. THE ORGANIZATION FOLLOWS THE U.S. DEPARTMENT OF TREASURY ANTI-TERRORIST FINANCING VOLUNTARY BEST PRACTICES GUIDELINES FOR CHARITIES. IN COMPLIANCE WITH THE BEST PRACTICES, THE ORGANIZATION COLLECTS AND REVIEWS INFORMATION ABOUT THE PROSPECTIVE GRANTEES AND CONDUCTS A VETTING PROCESS TO ENSURE THEY ARE NOT SUSPECTED OF ACTIVITIES RELATED TO TERRORISM. ONCE A GRANT IS APPROVED, A WRITTEN AGREEMENT IS SIGNED BY BOTH THE ORGANIZATION AND THE GRANTEE. FUNDING IS INCREMENTAL AND SPONSORED INSTITUTIONS ARE REQUIRED TO SUBMIT ANNUAL REPORTS OF EXPENDITURES AS WELL AS SCIENTIFIC PROGRESS REPORTS. SCIENTIFIC REPORTS ARE REVIEWED BY THE ORGANIZATION'S SCIENTIFIC STAFF TO DETERMINE PROGRESS. THE FINAL GRANT PAYMENT IS CONTINGENT UPON RECEIPT AND APPROVAL OF THE REPORT OF EXPENDITURES. REPORTS OF EXPENDITURES ARE REVIEWED AND APPROVED BY STAFF TO ENSURE INCURRED COSTS ARE APPROPRIATE. THE CF FOUNDATION'S INTERNAL AUDITORS CONDUCT AUDITS ON SAMPLES OF GRANT EXPENDITURE REPORTS BY EXAMINING SUPPORTING RECORDS FROM THE SPONSORED INSTITUTIONS. THE GRANTS IN THE MIDDLE EAST/NORTH AFRICA REGION WERE MADE TO BAR-ILAN UNIVERSITY AND HEBREW UNIVERSITY OF JERUSALEM, UNIVERSITIES IN ISRAEL.
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Schedule F (Form 990) 2015
Additional Data


Software ID:  
Software Version:  



Schedule I
(Form 990)
Department of the Treasury
Internal Revenue Service
Grants and Other Assistance to Organizations,
Governments and Individuals in the United States
Complete if the organization answered "Yes," on Form 990, Part IV, line 21 or 22.
lBullet Attach to Form 990.
lBullet Information about Schedule I (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2015
Open to Public
Inspection
Name of the organization
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC
 
Employer identification number
91-2059167
Part I
General Information on Grants and Assistance
1
Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ........................
2
Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.
Part II
Grants and Other Assistance to Domestic Organizations and Domestic Governments. Complete if the organization answered "Yes" on Form 990, Part IV, line 21, for any recipient
that received more than $5,000. Part II can be duplicated if additional space is needed.
(a) Name and address of organization
or government		 (b) EIN (c) IRC section
if applicable		 (d) Amount of cash grant (e) Amount of non-cash
assistance		 (f) Method of valuation
(book, FMV, appraisal,
other)		 (g) Description of
non-cash assistance		 (h) Purpose of grant
or assistance
(1) ALBANY MEDICAL COLLEGE
47 NEW SCOTLAND AVE
ALBANY,NY12208 		14-1338310 501C(3) 174,236       CLINICAL RESEARCH CENTER
(2) ALL CHILDREN'S HOSPITAL
DEPT 9010
ST PETERSBURG,FL33731 		59-0683252 501C(3) 242,316       CLINICAL RESEARCH CENTER
(3) ANN AND ROBERT H LURIE CHILDREN'S HOSPITAL OF CHI
2300 CHILDRENS PLAZA
CHICAGO,IL60614 		36-3357006 501C(3) 39,279       CLINICAL RESEARCH
(4) ANN AND ROBERT H LURIE CHILDREN'S HOSPITAL OF CHI
2300 CHILDRENS PLAZA
CHICAGO,IL60614 		36-3357006 501C(3) 203,469       CLINICAL RESEARCH CENTER
(5) ANN AND ROBERT H LURIE CHILDREN'S HOSPITAL OF CHI
2300 CHILDRENS PLAZA
CHICAGO,IL60614 		36-3357006 501C(3) 17,531       CLINICAL RESEARCH STUDY
(6) ANN AND ROBERT H LURIE CHILDREN'S HOSPITAL OF CHI
2300 CHILDRENS PLAZA
CHICAGO,IL60614 		36-3357006 501C(3) 162,000       THERAPEUTICS DISCOVERY RESEARCH
(7) ARIZONA BOARD OF REGENTS UNIVERSITY OF ARIZONA
888 N EUCLID
TUCSON,AZ85722 		74-2652689 IRC 115 237,695       THERAPEUTICS DISCOVERY RESEARCH
(8) ARIZONA BOARD OF REGENTS UNIVERSITY OF ARIZONA
888 N EUCLID
TUCSON,AZ85722 		74-2652689 IRC 115 27,000       ADHERENCE
(9) ARIZONA BOARD OF REGENTS UNIVERSITY OF ARIZONA
888 N EUCLID
TUCSON,AZ85722 		74-2652689 IRC 115 181,186       CLINICAL RESEARCH CENTER
(10) ARIZONA BOARD OF REGENTS UNIVERSITY OF ARIZONA
888 N EUCLID
TUCSON,AZ85722 		74-2652689 IRC 115 228,778       CLINICAL RESEARCH STUDY
(11) ATLANTIC HEALTH SYSTEM
100 MADISON AVENUE
MORRISTOWN,NJ07962 		52-1958352 501C(3) 326,345       CLINICAL RESEARCH CENTER
(12) BAYLOR COLLEGE OF MEDICINE
PO BOX 1
HOUSTON,TX77212 		74-1613878 501C(3) 67,981       CLINICAL RESEARCH
(13) BAYLOR COLLEGE OF MEDICINE
PO BOX 1
HOUSTON,TX77212 		74-1613878 501C(3) 378,132       CLINICAL RESEARCH CENTER
(14) BETH ISRAEL MEDICAL CENTER
160 WATER STREET
NEW YORK,NY10038 		13-5564934 501C(3) 268,845       CLINICAL RESEARCH CENTER
(15) BOARD OF REGENTS OF THE UNIVERSITY OF WISCONSIN SY
21 N PARK ST
MADISON,WI537151218 		39-6006492 IRC 115 270,801       CLINICAL RESEARCH CENTER
(16) BOARD OF REGENTS OF THE UNIVERSITY OF WISCONSIN SY
21 N PARK ST
MADISON,WI537151218 		39-6006492 IRC 115 447,873       CLINICAL RESEARCH STUDY
(17) BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UN
651 SERRA STREET
STANFORD,CA943056215 		94-1156365 501C(3) 27,000       ADHERENCE
(18) BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UN
651 SERRA STREET
STANFORD,CA943056215 		94-1156365 501C(3) 312,836       CLINICAL RESEARCH CENTER
(19) BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UN
651 SERRA STREET
STANFORD,CA943056215 		94-1156365 501C(3) 216,000       THERAPEUTICS DISCOVERY RESEARCH
(20) CASE WESTERN RESERVE UNIVERSITY
10900 EUCLID AVENUE
CLEVELAND,OH441067015 		34-1018992 501C(3) 534,453       CLINICAL RESEARCH CENTER
(21) CASE WESTERN RESERVE UNIVERSITY
10900 EUCLID AVENUE
CLEVELAND,OH441067037 		34-1018992 501C(3) 1,273,475       THERAPEUTICS DISCOVERY RESEARCH
(22) CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BOULEVARD
LOS ANGELES,CA90048 		95-1644600 501C(3) 162,000       THERAPEUTICS DISCOVERY RESEARCH
(23) CHILDREN'S HEALTH CARE
2525 CHICAGO AVENUE SOUTH
MINNEAPOLIS,MN554041844 		41-1754276 501C(3) 6,316       CLINICAL RESEARCH
(24) CHILDREN'S HEALTH CARE
2525 CHICAGO AVENUE SOUTH
MINNEAPOLIS,MN554041844 		41-1754276 501C(3) 168,024       CLINICAL RESEARCH CENTER
(25) CHILDREN'S HOSPITAL CORPORATION (BOSTON CHILDREN'S
300 LONGWOOD AVENUE
BOSTON,MA02115 		04-2774441 501C(3) 45,821       ACADEMIC ADVISORY AWARD
(26) CHILDREN'S HOSPITAL CORPORATION (BOSTON CHILDREN'S
300 LONGWOOD AVENUE
BOSTON,MA02115 		04-2774441 501C(3) 392,973       ADHERENCE
(27) CHILDREN'S HOSPITAL CORPORATION (BOSTON CHILDREN'S
300 LONGWOOD AVENUE
BOSTON,MA02115 		04-2774441 501C(3) 314,179       CLINICAL RESEARCH CENTER
(28) CHILDREN'S HOSPITAL CORPORATION (BOSTON CHILDREN'S
300 LONGWOOD AVENUE
BOSTON,MA02115 		04-2774441 501C(3) 208,250       THERAPEUTICS DISCOVERY RESEARCH
(29) CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE
CINCINNATI,OH45229 		31-0833936 501C(3) 22,913       ACADEMIC ADVISORY AWARD
(30) CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE
CINCINNATI,OH45229 		31-0833936 501C(3) 27,000       ADHERENCE
(31) CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE
CINCINNATI,OH45229 		31-0833936 501C(3) 108,731       CLINICAL RESEARCH
(32) CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE
CINCINNATI,OH45229 		31-0833936 501C(3) 177,693       CLINICAL RESEARCH CENTER
(33) CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE
CINCINNATI,OH45229 		31-0833936 501C(3) 1,077,843       CLINICAL RESEARCH STUDY
(34) CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE
CINCINNATI,OH45229 		31-0833936 501C(3) 344,664       THERAPEUTICS DISCOVERY RESEARCH
(35) CHILDREN'S HOSPITAL MEDICAL CENTER OF AKRON
1 PERKINS SQUARE
AKRON,OH44308 		34-0714357 501C(3) 89,662       CLINICAL RESEARCH CENTER
(36) CHILDREN'S HOSPITAL LOS ANGELES
4650 SUNSET BLVD
LOS ANGELES,CA90027 		95-1690977 501C(3) 148,296       CLINICAL RESEARCH CENTER
(37) CHILDREN'S MEDICAL CENTER
ONE CHILDRENS PLAZA
DAYTON,OH45404 		31-0672132 501C(3) 158,148       CLINICAL RESEARCH CENTER
(38) CONNECTICUT CHILDREN'S MEDICAL CENTER
282 WASHINGTON STREET
HARTFORD,CT06106 		06-0646755 501C(3) 67,669       CLINICAL RESEARCH CENTER
(39) COOK CHILDREN'S MEDICAL CENTER
801 SEVENTH AVENUE
FT WORTH,TX76104 		75-2051646 501C(3) 270,377       CLINICAL RESEARCH CENTER
(40) DANA-FARBER CANCER INSTITUTE
450 BROOKLINE AVENUE
BOSTON,MA022155450 		04-2263040 501C(3) 162,000       THERAPEUTICS DISCOVERY RESEARCH
(41) PHILADELPHIA HEALTH & EDUCATION CORPORATION
3201 ARCH STREET
PHILADELPHIA,PA19104 		23-2979433 501C(3) 93,186       CLINICAL RESEARCH CENTER
(42) EMORY UNIVERSITY
1784 N DECATUR ROAD
ATLANTA,GA30322 		58-0566256 501C(3) 332,952       CLINICAL RESEARCH CENTER
(43) EMORY UNIVERSITY
1784 N DECATUR ROAD
ATLANTA,GA30322 		58-0566256 501C(3) 108,000       CLINICAL RESEARCH STUDY
(44) EMORY UNIVERSITY
1784 N DECATUR ROAD
ATLANTA,GA30322 		58-0566256 501C(3) 495,609       THERAPEUTICS DISCOVERY RESEARCH
(45) GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTIT
1120 15TH STREET
AUGUSTA,GA309124810 		58-1418202 501C(3) 116,053       CLINICAL RESEARCH STUDY
(46) GEORGIA INSTITUTE OF TECHNOLOGY
505 10TH STREET
ATLANTA,GA30332 		58-6002023 IRC 115 264,611       THERAPEUTICS DISCOVERY RESEARCH
(47) KAISER FOUNDATION RESEARCH INSTITUTE
1800 HARRISON STREET
OAKLAND,CA94612 		94-1105628 501C(3) 159,548       CLINICAL RESEARCH CENTER
(48) KAISER FOUNDATION RESEARCH INSTITUTE
1800 HARRISON STREET
OAKLAND,CA94612 		94-1105628 501C(3) 57,979       CLINICAL RESEARCH STUDY
(49) LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER
642 CSRB 533 BOLIVAR ST
NEW ORLEANS,LA70112 		72-6087770 115 162,000       THERAPEUTICS DISCOVERY RESEARCH
(50) MAINE MEDICAL CENTER
22 BRAMHALL STREET
PORTLAND,ME041023175 		01-0238552 501C(3) 140,292       CLINICAL RESEARCH CENTER
(51) MEDICAL UNIVERSITY OF SOUTH CAROLINA
PO BOX 997
CHARLESTON,SC29402 		57-6000722 115 207,863       CLINICAL RESEARCH CENTER
(52) MEDICAL UNIVERSITY OF SOUTH CAROLINA
PO BOX 997
CHARLESTON,SC29402 		57-6000722 115 31,486       CLINICAL RESEARCH STUDY
(53) MEMORIAL CHILDREN'S HOSPITAL
2801 ATLANTIC AVENUE
LONG BEACH,CA90806 		95-3527031 501C(3) 300,657       CLINICAL RESEARCH CENTER
(54) MEMORIAL SLOAN KETTERING CANCER CENTER
485 LEXINGTON AVENUE
NEW YORK,NY10017 		13-1924236 501C(3) 54,097       CLINICAL RESEARCH STUDY
(55) MONMOUTH MEDICAL CENTER FOUNDATION
300 SECOND AVENUE
LONG BRANCH,NJ07740 		22-2456079 501C(3) 72,203       CLINICAL RESEARCH CENTER
(56) NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
1400 JACKSON STREET
DENVER,CO80206 		74-2044647 501C(3) 27,000       ADHERENCE
(57) NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
1400 JACKSON STREET
DENVER,CO80206 		74-2044647 501C(3) 187,775       CLINICAL RESEARCH CENTER
(58) NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
1400 JACKSON STREET
DENVER,CO80206 		74-2044647 501C(3) 395,353       CLINICAL RESEARCH STUDY
(59) NEMOURS CHILDREN'S CLINIC ORLANDO
10140 CENTURION PARKWAY NORTH
JACKSONVILLE,FL32256 		59-0634433 501C(3) 127,526       CLINICAL RESEARCH CENTER
(60) NORTHWESTERN UNIVERSITY
633 CLARK STREET
EVANSTON,IL60208 		36-2167817 501C(3) 27,000       ADHERENCE
(61) NORTHWESTERN UNIVERSITY
633 CLARK STREET
EVANSTON,IL60208 		36-2167817 501C(3) 130,181       CLINICAL RESEARCH CENTER
(62) OREGON HEALTH & SCIENCE UNIVERSITY
0690 SW BANCROFT STREET
PORTLAND,OR97239 		23-7083114 501C(3) 24,984       CLINICAL RESEARCH
(63) OREGON HEALTH & SCIENCE UNIVERSITY
0690 SW BANCROFT STREET
PORTLAND,OR97239 		23-7083114 501C(3) 206,774       CLINICAL RESEARCH CENTER
(64) OREGON HEALTH & SCIENCE UNIVERSITY
0690 SW BANCROFT STREET
PORTLAND,OR97239 		23-7083114 501C(3) 507,192       THERAPEUTICS DISCOVERY RESEARCH
(65) OSF SAINT FRANCIS MEDICAL CENTER
420 NE GLEN OAK AVENUE
PEORIA,IL61603 		37-0662569 501C(3) 83,238       CLINICAL RESEARCH CENTER
(66) PENNSYLVANIA STATE UNIVERSITY
OFFICE OF RESEARCH AFFAIRS
HERSHEY,PA17033 		24-6000376 115 111,433       CLINICAL RESEARCH CENTER
(67) PROVIDENCE ALASKA MEDICAL CENTER
4045 LAKE OTIS PKWY
ANCHORAGE,AK99508 		92-0016429 501C(3) 70,040       CLINICAL RESEARCH CENTER
(68) REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
ANSCHUTZ MEDICAL CAMPUS
AURORA,CO80045 		84-6000555 501C(3) 346,088       THERAPEUTICS DISCOVERY RESEARCH
(69) REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
ANSCHUTZ MEDICAL CAMPUS
AURORA,CO80045 		84-6000555 501C(3) 23,441       ACADEMIC ADVISORY AWARD
(70) REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
ANSCHUTZ MEDICAL CAMPUS
AURORA,CO80045 		84-6000555 501C(3) 26,668       ADHERENCE
(71) REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
ANSCHUTZ MEDICAL CAMPUS
AURORA,CO80045 		84-6000555 501C(3) 568,442       CLINICAL RESEARCH
(72) REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
ANSCHUTZ MEDICAL CAMPUS
AURORA,CO80045 		84-6000555 501C(3) 288,972       CLINICAL RESEARCH CENTER
(73) REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
ANSCHUTZ MEDICAL CAMPUS
AURORA,CO80045 		84-6000555 501C(3) 316,720       CLINICAL RESEARCH STUDY
(74) THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW
PO BOX 9
ALBANY,NY122010009 		14-1368361 501C(3) 54,000       ADHERENCE
(75) THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW
PO BOX 9
ALBANY,NY122010009 		14-1368361 501C(3) 96,526       CLINICAL RESEARCH
(76) THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW
PO BOX 9
ALBANY,NY122010009 		14-1368361 501C(3) 415,644       CLINICAL RESEARCH CENTER
(77) RUTGERS THE STATE UNIVERSITY OF NEW JERSEY
3 RUTGERS PLAZA
NEW BRUNSWICK,NJ08901 		46-2354111 IRC 115 181,062       CLINICAL RESEARCH CENTER
(78) SANFORD CHILDRENS SPECIALITY CLINIC
1600 W 22 STREET
SIOUX FALLS,SD57105 		46-0447693 501C(3) 181,290       CLINICAL RESEARCH CENTER
(79) SEATTLE CHILDREN'S HOSPITAL
4800 SAND POINT WAY NE
SEATTLE,WA98105 		91-0564748 501C(3) 7,829,983       CLINICAL RESEARCH
(80) SEATTLE CHILDREN'S HOSPITAL
4800 SAND POINT WAY NE
SEATTLE,WA98105 		91-0564748 501C(3) 4,350,544       CLINICAL RESEARCH CENTER
(81) SEATTLE CHILDREN'S HOSPITAL
4800 SAND POINT WAY NE
SEATTLE,WA98105 		91-0564748 501C(3) 2,200,704       CLINICAL RESEARCH STUDY
(82) SETON HEALTHCARE DELL CHILDREN'S
4900 MUELLER BLVD
AUSTIN,TX78723 		74-1109643 501C(3) 163,609       CLINICAL RESEARCH CENTER
(83) SPECTRUM HEALTH FOUNDATION
100 MICHIGAN STREET NE
GRAND RAPIDS,MI49503 		38-2752328 501C(3) 156,618       CLINICAL RESEARCH CENTER
(84) ST LOUIS UNIVERSITY
3500 LINDELL BLVD
ST LOUIS,MO63103 		43-0654872 501C(3) 168,935       CLINICAL RESEARCH CENTER
(85) ST LUKE'S REGIONAL MEDICAL CENTER
100 EAST IDAHO
BOISE,ID83712 		82-0161600 501C(3) 101,594       CLINICAL RESEARCH CENTER
(86) TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER
3601 4TH STREET
LUBBOCK,TX79430 		75-2668014 IRC 115 164,866       THERAPEUTICS DISCOVERY RESEARCH
(87) THE CHILDREN'S HOSPITAL OF PHILADELPHIA
34TH AND CIVIC CENTER BOULEVARD
PHILADELPHIA,PA19104 		23-1352166 501C(3) 49,105       CLINICAL RESEARCH
(88) THE CHILDREN'S HOSPITAL OF PHILADELPHIA
34TH AND CIVIC CENTER BOULEVARD
PHILADELPHIA,PA19104 		23-1352166 501C(3) 224,658       CLINICAL RESEARCH CENTER
(89) THE CHILDREN'S MERCY HOSPITAL
2401 GILLHAM ROAD
KANSAS CITY,MO61408 		44-0605373 501C(3) 64,749       CLINICAL RESEARCH
(90) THE CHILDREN'S MERCY HOSPITAL
2401 GILLHAM ROAD
KANSAS CITY,MO61408 		44-0605373 501C(3) 194,878       CLINICAL RESEARCH CENTER
(91) THE CURATORS OF THE UNIVERSITY OF MISSOURI
310 JESSE HALL
COLUMBIA,MO65211 		43-6003859 IRC 115 22,156       THERAPEUTICS DISCOVERY RESEARCH
(92) THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
350 COMMUNITY DRIVE
MANHASSET,NY11030 		11-2673595 501C(3) 173,140       CLINICAL RESEARCH CENTER
(93) THE GENERAL HOSPITAL CORPORATION (MASSACHUSETTS GE
PO BOX 414876
BOSTON,MA022414876 		04-2697983 501C(3) 174,707       CLINICAL RESEARCH CENTER
(94) THE GENERAL HOSPITAL CORPORATION (MASSACHUSETTS GE
PO BOX 414876
BOSTON,MA022414876 		04-2697983 501C(3) 211,741       THERAPEUTICS DISCOVERY RESEARCH
(95) THE HITCHCOCK FOUNDATION
ONE MEDICAL CENTER DRIVE
LEBANON,NH03756 		02-0222139 501C(3) 225,985       CLINICAL RESEARCH CENTER
(96) THE HITCHCOCK FOUNDATION
ONE MEDICAL CENTER DRIVE
LEBANON,NH03756 		02-0222139 501C(3) 106,375       CLINICAL RESEARCH STUDY
(97) THE JOHNS HOPKINS UNIVERSITY
600 N WOLFE STREET
BALTIMORE,MD21205 		52-0595110 501C(3) 288,562       ADHERENCE
(98) THE JOHNS HOPKINS UNIVERSITY
600 N WOLFE STREET
BALTIMORE,MD21205 		52-0595110 501C(3) 397,969       CLINICAL RESEARCH CENTER
(99) THE JOHNS HOPKINS UNIVERSITY
600 N WOLFE STREET
BALTIMORE,MD21205 		52-0595110 501C(3) 1,165,166       CLINICAL RESEARCH STUDY
(100) THE JOHNS HOPKINS UNIVERSITY
600 N WOLFE STREET
BALTIMORE,MD21205 		52-0595110 501C(3) 897,363       THERAPEUTICS DISCOVERY RESEARCH
(101) THE MEDICAL COLLEGE OF WISCONSIN
8701 WATERTOWN PLK RD
MILWAUKEE,WI53226 		39-0806261 501C(3) 232,145       CLINICAL RESEARCH CENTER
(102) THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGI
PO BOX 400195
CHARLOTTESVILLE,VA229044195 		54-6001796 501C(3) 166,460       CLINICAL RESEARCH CENTER
(103) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN D
9500 GILMAN DRIVE
LA JOLLA,CA920930984 		95-6006144 501C(3) 187,490       CLINICAL RESEARCH CENTER
(104) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN D
9500 GILMAN DRIVE
LA JOLLA,CA920930984 		95-6006144 501C(3) 144,000       THERAPEUTICS DISCOVERY RESEARCH
(105) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN F
3333 CALIFORNIA STREET
SAN FRANCISCO,CA941430962 		95-6006144 501C(3) 161,200       THERAPEUTICS DISCOVERY RESEARCH
(106) THE REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 SOUTH STATE STREET
ANN ARBOR,MI481091274 		38-6006309 501C(3) 26,214       ADHERENCE
(107) THE REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 SOUTH STATE STREET
ANN ARBOR,MI481091274 		38-6006309 501C(3) 214,351       CLINICAL RESEARCH CENTER
(108) THE REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 SOUTH STATE STREET
ANN ARBOR,MI481091274 		38-6006309 501C(3) 566,002       CLINICAL RESEARCH STUDY
(109) THE REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 SOUTH STATE STREET
ANN ARBOR,MI481091274 		38-6006309 501C(3) 81,000       THERAPEUTICS DISCOVERY RESEARCH
(110) THE REGENTS OF THE UNIVERSITY OF MINNESOTA
200 OAK STREET SE
MINNEAPOLIS,MN554552070 		41-6007513 IRC 115 45,988       ACADEMIC ADVISORY AWARD
(111) THE REGENTS OF THE UNIVERSITY OF MINNESOTA
200 OAK STREET SE
MINNEAPOLIS,MN554552070 		41-6007513 IRC 115 86,967       CLINICAL RESEARCH
(112) THE REGENTS OF THE UNIVERSITY OF MINNESOTA
200 OAK STREET SE
MINNEAPOLIS,MN554552070 		41-6007513 IRC 115 297,470       CLINICAL RESEARCH CENTER
(113) THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HO
700 CHILDRENS DRIVE
COLUMBUS,OH43205 		31-6056230 501C(3) 332,655       CLINICAL RESEARCH CENTER
(114) THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HO
700 CHILDRENS DRIVE
COLUMBUS,OH43205 		31-6056230 501C(3) 199,594       THERAPEUTICS DISCOVERY RESEARCH
(115) THE SCRIPPS RESEARCH INSTITUTE
10666 NORTH TORREY PINES ROAD
LA JOLLA,CA92037 		33-0435954 501C(3) 193,350       THERAPEUTICS DISCOVERY RESEARCH
(116) THE TOLEDO HOSPITAL
2142 N COVE BLVD
TOLEDO,OH43606 		34-4428256 501C(3) 126,510       CLINICAL RESEARCH CENTER
(117) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF
PO BOX 29789
NEW YORK,NY100879789 		13-5598093 501C(3) 391,865       CLINICAL RESEARCH CENTER
(118) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF
PO BOX 29789
NEW YORK,NY100879789 		13-5598093 501C(3) 223,619       CLINICAL RESEARCH STUDY
(119) THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE S
BIRMINGHAM,AL352940006 		63-6005396 501C(3) 56,760       ACADEMIC ADVISORY AWARD
(120) THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE S
BIRMINGHAM,AL352940006 		63-6005396 501C(3) 27,000       ADHERENCE
(121) THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE S
BIRMINGHAM,AL352940006 		63-6005396 501C(3) 218,156       CLINICAL RESEARCH
(122) THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE S
BIRMINGHAM,AL352940006 		63-6005396 501C(3) 366,078       CLINICAL RESEARCH CENTER
(123) THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE S
BIRMINGHAM,AL352940006 		63-6005396 501C(3) 1,208,857       THERAPEUTICS DISCOVERY RESEARCH
(124) THE UNIVERSITY OF CHICAGO
970 E 58TH STREET
CHICAGO,IL60637 		36-2177139 501C(3) 26,061       ACADEMIC ADVISORY AWARD
(125) THE UNIVERSITY OF IOWA
OFFICE OF VP FOR RESEARCH
IOWA CITY,IA52242 		42-6004813 IRC 115 218,397       CLINICAL RESEARCH CENTER
(126) THE UNIVERSITY OF IOWA
OFFICE OF VP FOR RESEARCH
IOWA CITY,IA52242 		42-6004813 IRC 115 2,239,943       THERAPEUTICS DISCOVERY RESEARCH
(127) THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
300 BYNUM HALL
CHAPEL HILL,NC275994100 		56-6001393 501C(3) 24,181       ACADEMIC ADVISORY AWARD
(128) THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
300 BYNUM HALL
CHAPEL HILL,NC275994100 		56-6001393 501C(3) 83,221       CLINICAL RESEARCH
(129) THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
300 BYNUM HALL
CHAPEL HILL,NC275994100 		56-6001393 501C(3) 435,446       CLINICAL RESEARCH CENTER
(130) THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
300 BYNUM HALL
CHAPEL HILL,NC275994100 		56-6001393 501C(3) 276,707       CLINICAL RESEARCH STUDY
(131) THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
300 BYNUM HALL
CHAPEL HILL,NC275994100 		56-6001393 501C(3) 1,243,723       THERAPEUTICS DISCOVERY RESEARCH
(132) THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT H
PO BOX 203382
HOUSTON,TX77216 		74-1761309 IRC 115 380,000       THERAPEUTICS DISCOVERY RESEARCH
(133) THE UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE
SALT LAKE CITY,UT84112 		87-6000525 501C(3) 301,289       CLINICAL RESEARCH CENTER
(134) THE UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE
SALT LAKE CITY,UT84112 		87-6000525 501C(3) 465,237       CLINICAL RESEARCH STUDY
(135) THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL C
223 WATERMAN BLDG
BURLINGTON,VT05405 		03-0179440 501C(3) 147,424       CLINICAL RESEARCH CENTER
(136) THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL C
223 WATERMAN BLDG
BURLINGTON,VT05405 		03-0179440 501C(3) 150,000       THERAPEUTICS DISCOVERY RESEARCH
(137) TRUSTEES OF BOSTON UNIVERSITY
25 BUICK STREET
BOSTON,MA02215 		04-2103547 501C(3) 81,000       THERAPEUTICS DISCOVERY RESEARCH
(138) TRUSTEES OF INDIANA UNIVERSITY
PO BOX 66057
INDIANAPOLIS,IN462666057 		35-6001673 501C(3) 382,742       CLINICAL RESEARCH CENTER
(139) TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
133 SOUTH 36TH STREET
PHILADELPHIA,PA191043246 		23-1352685 501C(3) 55,102       CLINICAL RESEARCH CENTER
(140) UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES
239 BRYANT STREET
BUFFALO,NY14222 		16-1238821 501C(3) 12,636       CLINICAL RESEARCH
(141) UNIVERSITY OF ALABAMA IN HUNTSVILLE
301 SPARKMAN DRIVE SW
HUNSTVILLE,AL35899 		63-0520830 501C(3) 145,126       THERAPEUTICS DISCOVERY RESEARCH
(142) UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES
4301 WEST MARKHAM STREET
LITTLE ROCK,AR72205 		71-6046242 IRC 115 98,960       CLINICAL RESEARCH CENTER
(143) UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY
231 ALBERT SABIN WAY
CINCINNATI,OH45267 		31-1435820 501C(3) 153,539       CLINICAL RESEARCH CENTER
(144) UNIVERSITY OF COLORADO HEALTH SCIENCES CENTER
4200 E 9TH AVENUE
DENVER,CO80262 		84-6000555 501C(3) 856,012       CLINICAL RESEARCH STUDY
(145) UNIVERSITY OF FLORIDA
123 GRINTER HALL
GAINESVILLE,FL32611 		59-6002052 IRC 115 135,845       CLINICAL RESEARCH CENTER
(146) UNIVERSITY OF FLORIDA
123 GRINTER HALL
GAINESVILLE,FL32611 		59-6002052 IRC 115 108,000       THERAPEUTICS DISCOVERY RESEARCH
(147) UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTH
WORCESTER,MA01655 		04-3167352 IRC 115 182,322       CLINICAL RESEARCH CENTER
(148) UNIVERSITY OF MIAMI
PO BOX 025405
MIAMI,FL331025405 		59-0624458 501C(3) 27,000       ADHERENCE
(149) UNIVERSITY OF MIAMI
PO BOX 025405
MIAMI,FL331025405 		59-0624458 501C(3) 189,505       CLINICAL RESEARCH CENTER
(150) UNIVERSITY OF NEBRASKA MEDICAL CENTER
985100 NEBRASKA MEDICAL CENTER
OMAHA,NE681985190 		47-0491233 501C(3) 210,962       CLINICAL RESEARCH CENTER
(151) UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER
PO BOX 26901
OKLAHOMA CITY,OK73190 		73-6017987 IRC 115 173,593       CLINICAL RESEARCH CENTER
(152) UNIVERSITY OF PITTSBURGH
PO BOX 371220
PITTSBURGH,PA15251 		25-0965591 501C(3) 108,000       THERAPEUTICS DISCOVERY RESEARCH
(153) UNIVERSITY OF PITTSBURGH
PO BOX 371220
PITTSBURGH,PA15251 		25-0965591 501C(3) 198,686       CLINICAL RESEARCH
(154) UNIVERSITY OF PITTSBURGH
PO BOX 371220
PITTSBURGH,PA15251 		25-0965591 501C(3) 371,309       CLINICAL RESEARCH CENTER
(155) UNIVERSITY OF PITTSBURGH
PO BOX 371220
PITTSBURGH,PA15251 		25-0965591 501C(3) 208,000       CLINICAL RESEARCH STUDY
(156) UNIVERSITY OF PITTSBURGH
PO BOX 371220
PITTSBURGH,PA15251 		25-0965591 501C(3) 470,505       THERAPEUTICS DISCOVERY RESEARCH
(157) UNIVERSITY OF ROCHESTER
601 ELMWOOD AVENUE
ROCHESTER,NY14642 		16-0743209 501C(3) 38,918       CLINICAL RESEARCH
(158) UNIVERSITY OF ROCHESTER
601 ELMWOOD AVENUE
ROCHESTER,NY14642 		16-0743209 501C(3) 158,787       CLINICAL RESEARCH CENTER
(159) UNIVERSITY OF ROCHESTER
601 ELMWOOD AVENUE
ROCHESTER,NY14642 		16-0743209 501C(3) 81,000       THERAPEUTICS DISCOVERY RESEARCH
(160) UNIVERSITY OF SOUTHERN CALIFORNIA
1540 ALCAZAR STREET
LOS ANGELES,CA90033 		95-1642394 501C(3) 153,247       CLINICAL RESEARCH CENTER
(161) UNIVERSITY OF SOUTHERN CALIFORNIA
1540 ALCAZAR STREET
LOS ANGELES,CA90033 		95-1642394 501C(3) 298,464       THERAPEUTICS DISCOVERY RESEARCH
(162) UNIVERSITY OF TENNESSEE
62 S DUNLAP
MEMPHIS,TN38163 		62-6001636 IRC 115 78,027       CLINICAL RESEARCH CENTER
(163) UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVENUE NE
SEATTLE,WA981056692 		91-6001537 IRC 115 243,000       THERAPEUTICS DISCOVERY RESEARCH
(164) UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVENUE NE
SEATTLE,WA981056692 		91-6001537 IRC 115 181,162       CLINICAL RESEARCH CENTER
(165) UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVENUE NE
SEATTLE,WA981056692 		91-6001537 IRC 115 100,000       CLINICAL RESEARCH STUDY
(166) UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVENUE NE
SEATTLE,WA981056692 		91-6001537 IRC 115 30,330       THERAPEUTICS DISCOVERY RESEARCH
(167) UT SOUTHWESTERN MEDICAL CENTER AT DALLAS
5323 HARRY HINES BOULEVARD
DALLAS,TX753909105 		75-6002868 IRC 115 325,724       CLINICAL RESEARCH CENTER
(168) UT SOUTHWESTERN MEDICAL CENTER AT DALLAS
5323 HARRY HINES BOULEVARD
DALLAS,TX753909105 		75-6002868 IRC 115 130,000       CLINICAL RESEARCH STUDY
(169) UT SOUTHWESTERN MEDICAL CENTER AT DALLAS
5323 HARRY HINES BOULEVARD
DALLAS,TX753909105 		75-6002868 IRC 115 465,736       THERAPEUTICS DISCOVERY RESEARCH
(170) VANDERBILT UNIVERSITY
PO BOX 30195
NASHVILLE,TN372410195 		62-0476822 501C(3) 109,021       CLINICAL RESEARCH CENTER
(171) VIA CHRISTI REGIONAL MEDICAL CENTER INC
707 N EMPORIA
WICHITA,KS67214 		48-1172106 501C(3) 65,991       CLINICAL RESEARCH CENTER
(172) VIRGINIA COMMONWEALTH UNIVERSITY
BOX 2506
RICHMOND,VA232842506 		54-6001758 IRC 115 27,000       ADHERENCE
(173) VIRGINIA COMMONWEALTH UNIVERSITY
BOX 2506
RICHMOND,VA232842506 		54-6001758 IRC 115 77,080       CLINICAL RESEARCH CENTER
(174) VIRGINIA COMMONWEALTH UNIVERSITY
BOX 2506
RICHMOND,VA232842506 		54-6001758 IRC 115 259,477       CLINICAL RESEARCH STUDY
(175) WAKE FOREST UNIVERSITY HEALTH SCIENCES
MEDICAL CENTER BLVD
WINSTONSALEM,NC271571064 		22-3849199 501C(3) 61,280       CLINICAL RESEARCH CENTER
(176) WASHINGTON UNIVERSITY
660 S EUCLID AVENUE
ST LOUIS,MO63110 		43-0653611 501C(3) 354,752       CLINICAL RESEARCH CENTER
(177) WAYNE STATE UNIVERSITY
RESEARCH AND SPONSORED PROGRAMS
DETROIT,MI48201 		38-3028425 501C(3) 185,704       CLINICAL RESEARCH CENTER
(178) WAYNE STATE UNIVERSITY
RESEARCH AND SPONSORED PROGRAMS
DETROIT,MI48201 		38-3028425 501C(3) 150,000       THERAPEUTICS DISCOVERY RESEARCH
(179) WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
1300 YORK AVENUE
NEW YORK,NY10021 		15-0532082 501C(3) 162,000       THERAPEUTICS DISCOVERY RESEARCH
(180) YALE UNIVERSITY
47 COLLEGE STREET
NEW HAVEN,CT065208047 		06-0646973 501C(3) 67,977       CLINICAL RESEARCH CENTER
(181) YALE UNIVERSITY
47 COLLEGE STREET
NEW HAVEN,CT065208047 		06-0646973 501C(3) 108,000       CLINICAL RESEARCH STUDY
(182) YALE UNIVERSITY
47 COLLEGE STREET
NEW HAVEN,CT065208047 		06-0646973 501C(3) 165,845       THERAPEUTICS DISCOVERY RESEARCH
2
Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................. Bullet Image
97
3
Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50055P
Schedule I (Form 990) 2015

Schedule I (Form 990) 2015
Page 2
Part III
Grants and Other Assistance to Domestic Individuals. Complete if the organization answered "Yes" on Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Number of
recipients		 (c) Amount of
cash grant		 (d) Amount of
non-cash assistance		 (e) Method of valuation (book,
FMV, appraisal, other)		 (f) Description of non-cash assistance
(1) FELLOWSHIP 1 7,000      
(1)
(2)
(3)
(4)
(5)
(6)
(7)
Part IV
Supplemental Information. Provide the information required in Part I, line 2, Part III, column (b), and any other additional information.
Return Reference Explanation
PROCEDURES FOR MONITORING GRANT FUNDS INSIDE OF THE U.S. PART I, LINE 2 THE ORGANIZATION HAS PROCEDURES IN PLACE TO MONITOR THE SCIENTIFIC PROGRESS AND FINANCIAL ASPECTS OF GRANT FUNDS AWARDED TO ENTITIES INSIDE OF THE U.S. SPONSORED INSTITUTIONS ARE REQUIRED TO SUBMIT ANNUAL REPORTS OF EXPENDITURES AS WELL AS SCIENTIFIC PROGRESS REPORTS. SCIENTIFIC REPORTS ARE REVIEWED BY THE ORGANIZATION'S SCIENTIFIC STAFF TO ENSURE PROGRESS HAS BEEN ATTAINED. THE FINAL GRANT PAYMENT IS CONTINGENT UPON RECEIPT AND APPROVAL OF THE REPORT OF EXPENDITURES. REPORTS OF EXPENDITURES ARE REVIEWED AND APPROVED BY STAFF TO ENSURE INCURRED COSTS ARE APPROPRIATE. THE CF FOUNDATION'S INTERNAL AUDITORS CONDUCT AUDITS ON SAMPLES OF GRANT EXPENDITURE REPORTS BY EXAMINING SUPPORTING RECORDS FROM THE SPONSORED INSTITUTION. SCHEDULE I, PART III FELLOWSHIPS ARE AWARDED TO INVESTIGATORS CONDUCTING RESEARCH RELATED TO GRANTS REPORTED IN PART II. SEE SUPPLEMENTAL INFORMATION FOR PART I, LINE 2 FOR PROCEDURES USED TO MONITOR THESE GRANTS. PRIOR TO MAKING FELLOWSHIP PAYMENTS, SUPPORTING DOCUMENTATION OF EXPENDITURES ARE REVIEWED AND APPROVED BY STAFF TO ENSURE INCURRED COSTS ARE APPROPRIATE.
Schedule I (Form 990) 2015



Additional Data


Software ID:  
Software Version:  


Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
SchJMediumBullet Attach to Form 990.
SchJMediumBullet Information about Schedule J (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2015
Open to Public Inspection
Name of the organization
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC
 
Employer identification number

91-2059167
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .........
1b
 
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked in line 1a? ..
2
 
 
3
Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
4
During the year, did any person listed on Form 990, Part VII, Section A, line 1a with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? ................
4a
Yes
 
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........
4b
Yes
 
c
Participate in, or receive payment from, an equity-based compensation arrangement? .........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.
5
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ...........................
5a
 
No
b
Any related organization?
5b
 
No
If "Yes," on line 5a or 5b, describe in Part III.
6
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization?
6a
 
No
b
Any related organization? .........................
6b
 
No
If "Yes," on line 6a or 6b, describe in Part III.
7
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any non-fixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
Yes
 
8
Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III .............................
8
 
No
9
If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
No
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50053T
Schedule J (Form 990) 2015

Schedule J (Form 990) 2015
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.
(A) Name and Title (B) Breakdown of W-2 and/or 1099-MISC compensation (C) Retirement and other deferred compensation (D) Nontaxable
benefits		 (E) Total of columns
(B)(i)-(D) 		(F) Compensation in column(B) reported as deferred on prior Form 990
(i) Base compensation (ii) Bonus & incentive compensation (iii) Other reportable compensation
1PRESTON CAMPBELL MDPRESIDENT & CEO (AS OF 10/1) (i)

(ii)		 144,690
-------------
284,125 		93,316
-------------
189,461 		7,565
-------------
23,384 		51,623
-------------
131,869 		0
-------------
29,049 		297,194
-------------
657,888 		30,544
-------------
62,015
2ROBERT BEALL PHDPRESIDENT & CEO (UNTIL 9/30) (i)

(ii)		 206,690
-------------
412,228 		135,956
-------------
276,031 		436,584
-------------
886,949 		20,043
-------------
67,754 		0
-------------
21,099 		799,273
-------------
1,664,061 		106,173
-------------
215,564
3C RICHARD MATTINGLYEXECUTIVE VP & COO (i)

(ii)		 0
-------------
316,273 		0
-------------
273,763 		0
-------------
2,128,337 		0
-------------
61,263 		0
-------------
7,283 		0
-------------
2,786,919 		0
-------------
682,855
4VERA H TWIGGEXECUTIVE VP, CFO & SECRETARY (i)

(ii)		 0
-------------
309,865 		0
-------------
167,491 		0
-------------
22,316 		0
-------------
78,919 		0
-------------
29,049 		0
-------------
607,640 		0
-------------
39,236
5BRUCE MARSHALL MDSENIOR VP OF CLINICAL AFFAIRS (i)

(ii)		 233,509
-------------
116,754 		77,062
-------------
13,000 		3,564
-------------
0 		32,060
-------------
0 		0
-------------
0 		346,195
-------------
129,754 		0
-------------
0
6MICHAEL P BOYLE MDSENIOR VP OF THERAPEUTICS DEV. (i)

(ii)		 238,947
-------------
0 		28,500
-------------
0 		908
-------------
0 		0
-------------
0 		14,595
-------------
0 		282,950
-------------
0 		0
-------------
0
7CHRIS PENLAND PHDVICE PRESIDENT OF RESEARCH (i)

(ii)		 110,144
-------------
110,144 		12,284
-------------
28,664 		0
-------------
704 		0
-------------
27,060 		0
-------------
26,245 		122,428
-------------
192,817 		0
-------------
0
8WILLIAM SKACH MDSENIOR VP OF RESEARCH AFFAIRS (i)

(ii)		 200,449
-------------
66,816 		29,498
-------------
8,071 		3,557
-------------
0 		20,704
-------------
0 		27,789
-------------
0 		281,997
-------------
74,887 		0
-------------
0
9DAVID MCLOUGHLINSR. VP OF OPERATIONS (i)

(ii)		 86,994
-------------
202,987 		21,107
-------------
49,249 		0
-------------
1,242 		0
-------------
32,060 		0
-------------
28,289 		108,101
-------------
313,827 		0
-------------
0
Schedule J (Form 990) 2015

Schedule J (Form 990) 2015
Page 3
Part III
Supplemental Information
Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.
Return Reference Explanation
PART I, LINE 4A - SEVERANCE PAYMENT MR. MATTINGLY RECEIVED SEVERANCE PAY FROM CYSTIC FIBROSIS FOUNDATION HEADQUARTERS ("CFF"), A RELATED ORGANIZATION, UPON HIS RETIREMENT AS EXECUTIVE VICE PRESIDENT AND COO OF CFF. HE HAD EXTRAORDINARY SUCCESSES ACHIEVED OVER HIS 37-YEAR TENURE. THE SEVERANCE WAS REVIEWED AND OPINED ON AS REASONABLE FROM A COMPETITIVE MARKET PERSPECTIVE BY THE CFF BOARDS INDEPENDENT COMPENSATION CONSULTANTS AND REVIEWED IN DETAIL AND APPROVED (IN THE MANNER SPECIFIED IN IRS REGULATIONS) BY THE CFF BOARD'S INDEPENDENT COMPENSATION COMMITTEE. ADDITIONAL INFORMATION, INCLUDING THE DOLLAR AMOUNT OF THE AWARD, IS PROVIDED IN THE ADDITIONAL INFORMATION FOR SCHEDULE J, PART II, BELOW.
PART I, LINE 4B - SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN CERTAIN PERSONS LISTED IN FORM 990, PART VII, SECTION A PARTICIPATE IN A NONQUALIFIED DEFERRED COMPENSATION PLAN SPONSORED BY CYSTIC FIBROSIS FOUNDATION HEADQUARTERS ("CFF"), A RELATED ORGANIZATION. THE EXECUTIVES PARTICIPATE BY VIRTUE OF BEING AN OFFICER OF CFF. HOWEVER, BOTH CFFT AND CFF MAKE CONTRIBUTIONS ON THE EXECUTIVES BEHALF IF THE EXECUTIVE RECEIVES COMPENSATION FROM CFFT (AS AN OFFICER OF CFFT) AND FROM CFF (AS AN OFFICER OF CFF). NONQUALIFIED DEFERRED COMPENSATION PLAN INTERESTS ARE FORFEITED BY THE PARTICIPANT IF THE PARTICIPANT VOLUNTARILY TERMINATES EMPLOYMENT PRIOR TO THE DESIGNATED VESTING DATE. FURTHER INFORMATION ABOUT THE NONQUALIFIED DEFERRED COMPENSATION PLAN IN WHICH THOSE PERSONS PARTICIPATE, INCLUDING THE AMOUNT OF ANY PAYMENT MADE BY THE PLAN DURING THE REPORTING YEAR, IS PROVIDED IN THE ADDITIONAL INFORMATION FOR SCHEDULE J, PART II, BELOW. PART I, LINE 7: SEVERAL INDIVIDUALS LISTED IN FORM 990, PART VII, SECTION A, LINE 1A, (WHO ARE IDENTIFIED IN PART II, BELOW) PARTICIPATED IN AN INCENTIVE COMPENSATION PLAN, FROM WHICH NON-FIXED PAYMENTS NOT DESCRIBED IN LINES 5 AND 6 WERE PAID. THE PLAN IS SPONSORED BY CFF, A RELATED ORGANIZATION. THE INDIVIDUALS PARTICIPATE BY VIRTUE OF BEING OFFICERS OF CFF. HOWEVER, IF AN INDIVIDUAL ALSO IS AN OFFICER OF CFFT AND RECEIVES COMPENSATION FROM CFFT, A PORTION OF THE INDIVIDUALS AWARD IS PAID BY CFFT. THE INCENTIVE COMPENSATION PLAN PAYS NON-FIXED PAYMENTS SUBJECT TO, AND BASED ON, THE ACHIEVEMENT OF ANNUAL PERFORMANCE OBJECTIVES ESTABLISHED IN ADVANCE BY THE COMPENSATION COMMITTEE. IN ADDITION, THE INCENTIVE COMPENSATION PLAN PAYS NON-FIXED PAYMENTS THAT RELATE TO A THREE-YEAR PERFORMANCE PERIOD, SUBJECT TO, AND BASED ON, THE ACHIEVEMENT OF LONG-TERM PERFORMANCE OBJECTIVES ESTABLISHED IN ADVANCE BY THE COMPENSATION COMMITTEE. ANY FINANCIAL PERFORMANCE OBJECTIVES ESTABLISHED UNDER THE INCENTIVE COMPENSATION PLAN DO NOT INCLUDE PROGRAM-RELATED REVENUES (SUCH AS ROYALTY STREAMS, LUMP-SUM PAYMENTS, OTHER PROGRAM-RELATED INCOME, AND SALES PROCEEDS FROM TRANSFER OF THE FOREGOING TO THIRD PARTIES) RELATED TO THE DEVELOPMENT AND APPROVAL OF CF DRUGS. PART II: CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. EIN 91-2059167. (A) NAME: P. CAMPBELL, M.D.; (B)(I) BASE COMPENSATION: BASE SALARY - $144,690; (B)(II) BONUS & INCENTIVE COMPENSATION: ANNUAL INCENTIVE PLAN BENEFIT (1) $29,772, LONG-TERM INCENTIVE PLAN PAYMENT, WHICH WAS PREVIOUSLY REPORTED (6) - $30,544, LONG-TERM INCENTIVE PLAN TREATMENT AWARD (3) - $33,000; (B)(III) OTHER REPORTABLE COMPENSATION: OTHER BENEFITS - $1,625; SECTION 457(B) PLAN (5) - $5,940; (C) DEFERRED COMPENSATION: LONG-TERM INCENTIVE PLAN BENEFIT (6) - $31,040, SERP (4) - $20,583; (D) NONTAXABLE BENEFITS: $0; (F) COMPENSATION REPORTED IN PRIOR FORM 990 (9) - $30,544. CYSTIC FIBROSIS FOUNDATION - HEADQUARTERS. EIN 13-1930701. (A) NAME: P. CAMPBELL, M.D.; (B)(I) BASE COMPENSATION: BASE SALARY - $284,125; (B)(II) BONUS & INCENTIVE COMPENSATION: ANNUAL INCENTIVE PLAN BENEFIT (1) $60,446, LONG-TERM INCENTIVE PLAN PAYMENT, WHICH WAS PREVIOUSLY REPORTED (6) - $62,015, LONG-TERM INCENTIVE PLAN TREATMENT AWARD (3) - $67,000; (B)(III) OTHER REPORTABLE COMPENSATION: OTHER BENEFITS INCLUDING TAXABLE GENERAL ORGANIZATION GROUP TERM LIFE INSURANCE PREMIUM - $11,324, SECTION 457(B) PLAN (5) - $12,060; (C) DEFERRED COMPENSATION: RETIREMENT BENEFIT (2) $27,060, LONG-TERM INCENTIVE PLAN BENEFIT (6) - $63,020, SERP (4) - $41,789; (D) NONTAXABLE BENEFITS: EMPLOYER CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $19,409, EMPLOYEE CONTRIBUTION TO FLEXIBLE SPENDING ACCOUNT BENEFIT - $2,550, EMPLOYEE CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $7,090; (F) COMPENSATION REPORTED IN PRIOR FORM 990 (9) - $62,015. CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. EIN 91-2059167. (A) NAME: R. BEALL, PH.D.; (B)(I) BASE COMPENSATION: BASE SALARY - $198,770, 401(K) BONUS $7,920; (B)(II) BONUS & INCENTIVE COMPENSATION: ANNUAL INCENTIVE PLAN BENEFIT (1) $48,263, LONG-TERM INCENTIVE PLAN PAYMENT, WHICH WAS PREVIOUSLY REPORTED (6) - $41,493, LONG-TERM INCENTIVE PLAN TREATMENT AWARD (3) - $46,200; (B)(III) OTHER REPORTABLE COMPENSATION: HEALTH INSURANCE BENEFIT - $1,606, AUTOMOBILE ALLOWANCE - $2,376, OTHER BENEFITS - $4,125, ADDITIONAL AWARD (7) - $330,000; VESTED SERP ACCOUNT (8) - $98,477; (C) DEFERRED COMPENSATION: LONG-TERM INCENTIVE PLAN BENEFIT (6) - $20,043; (D) NONTAXABLE BENEFITS: $0; (F) COMPENSATION REPORTED IN PRIOR FORM 990 (9) - $106,173; CYSTIC FIBROSIS FOUNDATION - HEADQUARTERS. EIN 13-1930701. (A) NAME: R. BEALL, PH.D.; (B)(I) BASE COMPENSATION: BASE SALARY - $396,148, 401(K) BONUS $16,080; (B)(II) BONUS & INCENTIVE COMPENSATION: ANNUAL INCENTIVE PLAN BENEFIT (1) $97,988, LONG-TERM INCENTIVE PLAN PAYMENT, WHICH WAS PREVIOUSLY REPORTED (6) - $84,244, LONG-TERM INCENTIVE PLAN TREATMENT AWARD (3) - $93,800; (B)(III) OTHER REPORTABLE COMPENSATION: HEALTH INSURANCE BENEFIT - $3,260, AUTOMOBILE ALLOWANCE - $4,824, OTHER BENEFITS - $8,925, ADDITIONAL AWARD (7) - $670,000, VESTED SERP ACCOUNT (8) $199,939; (C) DEFERRED COMPENSATION: RETIREMENT BENEFIT (2) $27,060, LONG-TERM INCENTIVE PLAN BENEFIT (6) - $40,694 ; (D) NONTAXABLE BENEFITS: EMPLOYER CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $13,683, EMPLOYEE CONTRIBUTION TO FLEXIBLE SPENDING ACCOUNT BENEFIT - $2,550, EMPLOYEE CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $4,866; (F) COMPENSATION REPORTED IN PRIOR FORM 990 (9) - $215,564. CYSTIC FIBROSIS FOUNDATION - HEADQUARTERS. EIN 13-1930701. (A) NAME: R. MATTINGLY; (B)(I) BASE COMPENSATION: BASE SALARY - $316,273; (B)(II) BONUS & INCENTIVE COMPENSATION: ANNUAL INCENTIVE PLAN BENEFIT (1) $80,081, LONG-TERM INCENTIVE PLAN PAYMENT, WHICH WAS PREVIOUSLY REPORTED (6) - $93,682, LONG-TERM INCENTIVE PLAN TREATMENT AWARD (3) - $100,000; (B)(III) OTHER REPORTABLE COMPENSATION: SECTION 457(B) PLAN (5) - $18,000; OTHER BENEFITS INCLUDING TAXABLE GENERAL ORGANIZATION GROUP TERM LIFE INSURANCE PREMIUM - $4,384; SEVERANCE AWARD (10) - $1,142,587, VESTED SERP ACCOUNT (11) $963,366; (C) DEFERRED COMPENSATION: RETIREMENT BENEFIT (2) $27,060, LONG-TERM INCENTIVE PLAN BENEFIT (6) - $34,203; (D) NONTAXABLE BENEFITS: EMPLOYER CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $5,650, EMPLOYEE CONTRIBUTION TO FLEXIBLE SPENDING ACCOUNT BENEFIT - $658, EMPLOYEE CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $975; (F) COMPENSATION REPORTED IN PRIOR FORM 990 (9) - $682,855. CYSTIC FIBROSIS FOUNDATION - HEADQUARTERS. EIN 13-1930701. (A) NAME: V. TWIGG; (B)(I) BASE COMPENSATION: BASE SALARY - $309,865; (B)(II) BONUS & INCENTIVE COMPENSATION: ANNUAL INCENTIVE PLAN BENEFIT (1) $58,255, LONG-TERM INCENTIVE PLAN PAYMENT, WHICH WAS PREVIOUSLY REPORTED (6) - $39,236, LONG-TERM INCENTIVE PLAN TREATMENT AWARD (3) - $70,000; (B)(III) OTHER REPORTABLE COMPENSATION: OTHER BENEFITS INCLUDING TAXABLE GENERAL ORGANIZATION GROUP TERM LIFE INSURANCE PREMIUM - $4,316, SECTION 457(B) PLAN (5) - $18,000; (C) DEFERRED COMPENSATION: RETIREMENT BENEFIT (2) $27,060, LONG-TERM INCENTIVE PLAN BENEFIT (6) - $48,153, SERP (4) - $3,706; (D) NONTAXABLE BENEFITS: EMPLOYER CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $19,409, EMPLOYEE CONTRIBUTION TO FLEXIBLE SPENDING ACCOUNT BENEFIT - $2,550, EMPLOYEE CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $7,090; (F) COMPENSATION REPORTED IN PRIOR FORM 990 (9) - $39,236 (1) THIS IS AN AWARD SUBJECT TO, AND BASED ON, ACHIEVEMENT OF ANNUAL PERFORMANCE STANDARDS ESTABLISHED IN ADVANCE BY THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES OF CYSTIC FIBROSIS FOUNDATION HEADQUARTERS ("CFF"), A RELATED ORGANIZATION. THE EXECUTIVE PARTICIPATES BY VIRTUE OF BEING AN OFFICER OF CFF. ANY FINANCIAL PERFORMANCE OBJECTIVES ESTABLISHED UNDER THE INCENTIVE COMPENSATION PLAN DO NOT INCLUDE PROGRAM-RELATED REVENUES (SUCH AS ROYALTY STREAMS, LUMP-SUM PAYMENTS, OTHER PROGRAM-RELATED INCOME, AND SALES PROCEEDS FROM TRANSFER OF THE FOREGOING TO THIRD PARTIES) RELATED TO THE DEVELOPMENT AND APPROVAL OF CF DRUGS. (2) THIS IS THE EMPLOYER CONTRIBUTION MADE UNDER THE CYSTIC FIBROSIS FOUNDATION 401(K) PLAN FOR THE 2015 PLAN YEAR. (3) THIS IS AN AWARD UNDER A PLAN SPONSORED BY CFF, A RELATED ORGANIZATION, WHICH PAYS A SPECIFIED DOLLAR AMOUNT ONLY IF AND WHEN THE FDA APPROVES CERTAIN PRE-SPECIFIED TYPES OF THERAPIES. IN THE EVENT THE EMPLOYEE TERMINATES EMPLOYMENT PRIOR TO FDA APPROVAL OF THE SPECIFIED THERAPY TYPE AND PAYMENT OF THE AWARD, THE EMPLOYEE WILL FORFEIT HIS OR HER RIGHT TO RECEIVE PAYMENT, UNLESS TERMINATION IS DUE TO RETIREMENT OR DISABILITY. THE PLAN WILL TERMINATE ON DECEMBER 31, 2018 UNLESS CFF DETERMINES TO EXTEND THE PLAN.
PART II - CONTINUED (4) THE SERP IS SPONSORED BY CFF, A RELATED ORGANIZATION. THE EXECUTIVE PARTICIPATES BY VIRTUE OF BEING AN OFFICER OF CFF. HOWEVER, BOTH CFFT AND CFF MAKE CONTRIBUTIONS ON THE EXECUTIVES BEHALF IF THE EXECUTIVE RECEIVES COMPENSATION FROM CFFT (AS AN OFFICER OF CFFT) AND FROM CFF (AS AN OFFICER OF CFF). A. THIS IS AN UNVESTED EMPLOYER CONTRIBUTION TO THE SERP. B. SERP INTERESTS ARE FORFEITED BY THE PARTICIPANT IF THE PARTICIPANT VOLUNTARILY TERMINATES EMPLOYMENT PRIOR TO ATTAINING THE VESTING DATE DESIGNATED BY CFF (WHICH IS EITHER A SPECIFIED AGE OR DATE, DEPENDING ON THE PARTICIPANT). C. SERP INTERESTS ARE HELD IN A TRUST SUBJECT TO THE CLAIMS OF CFF'S BANKRUPTCY CREDITORS. IN THE EVENT OF A CFF BANKRUPTCY, PARTICIPANTS WOULD BECOME GENERAL UNSECURED CREDITORS OF CFF. D. THE SERP IS A NONQUALIFIED DEFERRED COMPENSATION PLAN. THIS MEANS THAT PARTICIPANTS DO NOT RECEIVE THE TAX BENEFITS AVAILABLE TO PARTICIPANTS IN TAX QUALIFIED RETIREMENT PLANS. FOR EXAMPLE, UNDER CURRENT LAW, INTERESTS UNDER SERPS ARE REPORTABLE AS TAXABLE COMPENSATION WHEN THEY BECOME VESTED, EVEN IF THOSE AMOUNTS ARE NOT YET PAYABLE TO THE PARTICIPANT (AND EVEN IF THOSE AMOUNTS ARE NEVER PAID TO THE PARTICIPANT). E. THE SERP'S DESIGN WAS REVIEWED AND OPINED UPON AS REASONABLE BY AN INDEPENDENT COMPENSATION CONSULTANT. SERP CONTRIBUTION AMOUNTS WERE DETERMINED BY AN INDEPENDENT ACTUARY. F. CFF RETAINS THE RIGHT TO AMEND OR TERMINATE THE SERP AT ANY TIME. (5) THE 457(B) PLAN IS SPONSORED BY CFF, A RELATED ORGANIZATION. THE EXECUTIVE PARTICIPATES BY VIRTUE OF BEING AN OFFICER OF CFF. HOWEVER, BOTH CFFT AND CFF MAKE CONTRIBUTIONS ON THE EXECUTIVES BEHALF IF THE EXECUTIVE RECEIVES COMPENSATION FROM CFFT (AS AN OFFICER OF CFFT) AND FROM CFF (AS AN OFFICER OF CFF). A. THIS IS A VESTED CONTRIBUTION TO THE 457(B) PLAN FOR THE REPORTING PERIOD. B. IN THE EVENT OF A CFF BANKRUPTCY, PARTICIPANTS ARE GENERAL UNSECURED CREDITORS OF CFF. C. DISTRIBUTIONS FROM THE 457(B) PLAN MAY NOT BE ROLLED-OVER TO AN IRA OR QUALIFIED PLAN (BUT MAY ONLY BE ROLLED-OVER TO ANOTHER 457(B) PLAN). D. THE 457(B) PLAN'S DESIGN WAS REVIEWED AND OPINED UPON AS REASONABLE BY AN INDEPENDENT COMPENSATION CONSULTANT. AN INDEPENDENT ACTUARY DEVELOPED THE CONTRIBUTION FORMULA PURSUANT TO WHICH 457(B) CONTRIBUTION AMOUNTS ARE DETERMINED. CONTRIBUTIONS TO THE 457(B) PLAN ARE SUBJECT TO ANNUAL IRS LIMITS (CURRENTLY $18,000). E. CFF RETAINS THE RIGHT TO AMEND OR TERMINATE THE 457(B) PLAN AT ANY TIME. (6) THIS PLAN PROVIDES FOR AWARDS THAT RELATE TO A THREE-YEAR PERFORMANCE PERIOD, SUBJECT TO, AND BASED ON, ACHIEVEMENT OF PERFORMANCE OBJECTIVES ESTABLISHED IN ADVANCE BY THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES OF CFF, A RELATED ORGANIZATION. THE INDIVIDUALS PARTICIPATE BY VIRTUE OF BEING OFFICERS OF CFF. HOWEVER, IF AN INDIVIDUAL ALSO IS AN OFFICER OF CFFT AND RECEIVES COMPENSATION FROM CFFT, A PORTION OF THE INDIVIDUALS AWARD IS PAID BY CFFT. ANY FINANCIAL PERFORMANCE OBJECTIVES ESTABLISHED UNDER THE INCENTIVE COMPENSATION PLAN DO NOT INCLUDE PROGRAM-RELATED REVENUES (SUCH AS ROYALTY STREAMS, LUMP-SUM PAYMENTS, OTHER PROGRAM-RELATED INCOME, AND SALES PROCEEDS FROM TRANSFER OF THE FOREGOING TO THIRD PARTIES) RELATED TO THE DEVELOPMENT AND APPROVAL OF CF DRUGS. EACH YEAR, A NEW THREE-YEAR PERFORMANCE PERIOD BEGINS. AS REQUIRED BY THE FORM 990 INSTRUCTIONS, THE AMOUNTS REPORTED IN COLUMN (C) ON THIS FORM 990 REFLECT AN ESTIMATE OF THE PORTION OF EACH AWARD THAT THE EXECUTIVE ACCRUED UNDER THE PLAN FOR PERFORMANCE IN 2015 (I.E., WITH RESPECT TO THE 2013-2015, 2014-2016 AND THE 2015-2017 PERFORMANCE PERIODS), BUT THE AMOUNTS REPORTED IN COLUMN (C) HAVE NOT BEEN EARNED, AWARDED OR PAID UNDER THE PLAN. THE INDIVIDUAL MUST BE EMPLOYED ON 12/31/15, 12/31/16 AND 12/31/17 TO BE ELIGIBLE TO RECEIVE FULL PAYMENT OF THE AWARD FOR THE 2013-2015, 2014-2016, AND THE 2015-2017 PERFORMANCE PERIODS, RESPECTIVELY. THE AWARD RELATING TO THE 3-YEAR PERFORMANCE PERIOD ENDING 12/31/14 WAS PAID IN 2015, AND IS PROPERLY REPORTED AGAIN (AS COMPENSATION IN COLUMN (B)(II)) ON THIS FORM 990 (EVEN THOUGH AN ESTIMATE OF THE PORTION OF THIS AWARD THAT THE EXECUTIVE ACCRUED UNDER THE PLAN FOR PERFORMANCE IN 2014, 2013 AND 2012 WAS REPORTED IN COLUMN (C) OF THE FORM 990 FOR EACH OF THOSE YEARS). (7) THIS WAS AN AWARD PAID TO DR. BEALL UPON HIS RETIREMENT AS CEO OF CFF, FULFILLING THE TERMS OF HIS CONTRACT AND RECOGNIZING THE SIGNIFICANT CONTRIBUTIONS AND YEARS OF SERVICE (21-YEARS AS CEO AND 14-YEARS AS EXECUTIVE VICE PRESIDENT). THE AWARD WAS PAID BY CFFT WITH RESPECT TO HIS SERVICE AS AN OFFICER OF CFFT, AND BY CFF WITH RESPECT TO HIS SERVICE AS AN OFFICER OF CFF. THE AWARD WAS REVIEWED AND OPINED ON AS REASONABLE AND MARKET-COMPETITIVE BY THE CFF BOARD OF TRUSTEES INDEPENDENT COMPENSATION CONSULTANTS AND REVIEWED IN DETAIL AND APPROVED (IN THE MANNER SPECIFIED IN IRS REGULATIONS) BY THE CFF BOARDS INDEPENDENT COMPENSATION COMMITTEE. (8) THIS AMOUNT BECAME VESTED AND TAXABLE IN 2015 UNDER THE SERP DESCRIBED IN FOOTNOTE (4) ABOVE, UNDER WHICH DR. BEALL RECEIVED CONTRIBUTIONS FROM 2013-2015. AS REQUIRED, THE CONTRIBUTIONS TO THIS SERP THAT GENERATED THE AMOUNT REPORTED IN COLUMN B(III) OF THIS FORM 990 WERE REPORTED ON PRIOR YEARS' FORM 990S IN COLUMN (C). (9) THIS AMOUNT, ALTHOUGH ALSO INCLUDED IN COLUMN B OF THIS FORM 990, HAS ALREADY BEEN REPORTED AS COMPENSATION ON PRIOR YEARS' FORM 990S, AND THEREFORE (AS REQUIRED BY THE INSTRUCTIONS) IS DOUBLE-REPORTED HERE. (10) THIS WAS SEVERANCE PAID TO MR. MATTINGLY BY CFF UPON HIS RETIREMENT AS EXECUTIVE VICE PRESIDENT AND COO OF CFF, AFTER A 37-YEAR TENURE. THE AWARD WAS REVIEWED AND OPINED ON AS REASONABLE FROM A MARKET-COMPETITIVE STANDPOINT BY THE CFF BOARD OF TRUSTEES INDEPENDENT COMPENSATION CONSULTANTS AND REVIEWED IN DETAIL AND APPROVED (IN THE MANNER SPECIFIED IN IRS REGULATIONS) BY THE CFF BOARDS INDEPENDENT COMPENSATION COMMITTEE. (11) THIS AMOUNT BECAME VESTED AND TAXABLE IN 2015 UNDER THE SERP DESCRIBED IN FOOTNOTE (4) ABOVE, UNDER WHICH MR. MATTINGLY RECEIVED CONTRIBUTIONS FROM 2007-2015. AS REQUIRED, THE CONTRIBUTIONS TO THIS SERP THAT GENERATED THE AMOUNT REPORTED IN COLUMN B(III) OF THIS FORM 990 WERE REPORTED ON PRIOR YEARS' FORM 990S IN COLUMN (C).
Schedule J (Form 990) 2015
Additional Data


Software ID:  
Software Version:  
SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or 990-EZ or to provide any additional information.
MediumBullet Attach to Form 990 or 990-EZ.
MediumBullet Information about Schedule O (Form 990 or 990-EZ) and its instructions is at
www.irs.gov/form990.
OMB No. 1545-0047
2015
Open to Public
Inspection
Name of the organization
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC
 
Employer identification number

91-2059167
Return Reference Explanation
GOVERNING BODY APPOINTMENTS PART VI, SECTION A, LINE 7A THE MAJORITY OF THE ORGANIZATIONS BOARD MEMBERS ARE DESIGNATED BY THE BOARD OF TRUSTEES OF THE CYSTIC FIBROSIS FOUNDATION. THE OTHERS ARE EX-OFFICIO, APPOINTED TO THE BOARD BY THE BYLAWS.
REVIEW OF 990 BY GOVERNING BODY PART VI, SECTION B, LINE 11B THE ORGANIZATIONS BOARD OF DIRECTORS RECEIVES A DRAFT OF THE FORM 990 PRIOR TO ITS BEING FILED, WITH SUFFICIENT TIME FOR REVIEW AND COMMENT ALLOWED. THE ORGANIZATIONS ERISA ATTORNEYS REVIEW THE EXECUTIVE COMPENSATION SECTIONS OF THE FORM 990 TO ENSURE COMPLETENESS AND ACCURACY. THE AUDIT COMMITTEE ALSO REVIEWS THE FORM 990 AS PART OF ITS CHARTERED RESPONSIBILITIES. IN ALL CASES THE CYSTIC FIBROSIS FOUNDATION THERAPEUTICS BOARD OF DIRECTORS RECEIVED A COMPLETE COPY OF THE FINAL FORM 990 BEFORE IT IS FILED.
CONFLICT OF INTEREST MONITORING PART VI, SECTION B, LINE 12C A CONFLICT OF INTEREST DISCLOSURE STATEMENT IS COMPLETED ANNUALLY BY EACH BOARD MEMBER AND OFFICER. AS REQUIRED WITHIN THE BYLAWS, ANY POTENTIAL CONFLICTS OF INTEREST MUST BE REPORTED TO THE BOARD AS THEY ARISE. WHEN ANY MATTER IS DEEMED A POTENTIAL CONFLICT OF INTEREST AND REQUIRES ACTION BY THE BOARD OF DIRECTORS, THE INTERESTED DIRECTOR OR OFFICER IS REQUIRED TO RETIRE FROM THE ROOM IN WHICH THE BOARD IS MEETING, MAY NOT PARTICIPATE IN THE FINAL DELIBERATION OF THE MATTER, AND MAY NOT VOTE ON THE MATTER. THE ORGANIZATION ENFORCED THE POLICY DURING 2015 AND HAD NO CONFLICTS OF INTEREST AS DEFINED BY THE POLICY.
DETERMINING COMPENSATION PART VI, SECTION B, LINE 15A AND 15B THE TOTAL COMPENSATION OF EXECUTIVES AT THE ORGANIZATION IS SPECIFICALLY DESIGNED TO ATTRACT AND RETAIN THE HIGHEST QUALIFIED EXECUTIVE AND MEDICAL TALENT TO FULFILL THE CRITICALLY IMPORTANT MISSION OF CURING CYSTIC FIBROSIS AND PROVIDING ALL PEOPLE WITH THE DISEASE THE OPPORTUNITY TO LEAD FULL, PRODUCTIVE LIVES. CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. SHARES OFFICERS WITH CYSTIC FIBROSIS FOUNDATION, A RELATED ORGANIZATION. THE INDEPENDENT COMPENSATION COMMITTEE OF THE CF FOUNDATION'S BOARD OF TRUSTEES FOLLOWS THE PROCESS DESCRIBED IN THE IRS INTERMEDIATE SANCTIONS RULES WHEN DETERMINING COMPENSATION FOR EXECUTIVES OF THE ORGANIZATION. SPECIFICALLY, THE COMMITTEE: (1) IS COMPOSED ENTIRELY OF NON-EMPLOYEE VOLUNTEER DIRECTORS WHO HAVE NO FAMILIAL, BUSINESS OR SIGNIFICANT PERSONAL RELATIONSHIPS WITH THE ORGANIZATION OR ITS EXECUTIVES. (2) ASSESSES THE SHORT-TERM AND LONG-TERM CONTRIBUTION AND PERFORMANCE OF EACH EXECUTIVE IN MEETING VERY DEFINITIVE AND QUANTIFIABLE OBJECTIVES FOCUSED ON THE ORGANIZATION'S MISSION SUCCESS. (3) ENGAGES AN INDEPENDENT COMPENSATION CONSULTING FIRM TO COMPILE APPROPRIATE COMPARABILITY DATA (INCLUDING COMPENSATION MARKET INFORMATION FOR PEERS WITH WHOM THE ORGANIZATION COMPETES FOR EXECUTIVE TALENT) FOR COMMITTEE RELIANCE. THE COMMITTEE MEETS WITH REPRESENTATIVES OF THE CONSULTING FIRM TO REVIEW THIS DATA IN DETAIL. (4) REVIEWS ALL ELEMENTS OF EACH EXECUTIVE'S TOTAL COMPENSATION, INCLUDING BUT NOT LIMITED TO BASE SALARY, BONUSES, PERQUISITES, FRINGE BENEFITS, AND INCENTIVE AND DEFERRED COMPENSATION ARRANGEMENTS. UPON THE EXECUTIVES HIRE, AND AT EACH POINT IN TIME THEREAFTER AT WHICH A NEW OR REVISED COMPENSATION ARRANGEMENT IS UNDER CONSIDERATION WITH RESPECT TO THE EXECUTIVE, THE COMMITTEE MEETS WITH ITS INDEPENDENT COMPENSATION CONSULTING FIRM BEFORE THE ARRANGEMENT IS IMPLEMENTED TO EVALUATE THE REASONABLENESS OF THE ARRANGEMENT BY COMPARING BOTH THE ARRANGEMENT ITSELF AND THE EXECUTIVES ENTIRE COMPENSATION PACKAGE TO COMPENSATION PACKAGES PAID BY SIMILARLY SITUATED ORGANIZATIONS FOR FUNCTIONALLY COMPARABLE POSITIONS. (5) DOCUMENTS, CONCURRENTLY WITH ITS DETERMINATION, THE BASIS FOR ITS DETERMINATION IN THE MINUTES OF ITS MEETING. THESE MINUTES ARE REVIEWED, REVISED IF NECESSARY AND APPROVED AT THE FOLLOWING MEETING OF THE COMMITTEE. (6) OBTAINS A WRITTEN LEGAL OPINION CONCERNING THE COMMITTEES COMPLIANCE WITH THE IRS INTERMEDIATE SANCTIONS RULES. THE PROCESS DESCRIBED ABOVE WAS USED TO ESTABLISH COMPENSATION FOR THE FOLLOWING OFFICERS OF THE ORGANIZATION: PRESIDENT & CEO EXECUTIVE VICE PRESIDENT & COO EXECUTIVE VICE PRESIDENT, CFO AND SECRETARY THE PROCESS WAS LAST UNDERTAKEN IN 2014, WITH THE EXCEPTION OF THAT FOR THE CEO POSITION WHICH WAS LAST CONDUCTED IN 2015.
PUBLIC INSPECTION PART VI, SECTION C THE FORM 1023 FOR THE ORGANIZATION WAS AVAILABLE ON ITS WEBSITE, CFF.ORG, AND THE ORGANIZATION'S WEBSITE PROVIDES A DIRECT LINK TO ITS FORM 990 ON GUIDESTAR.ORG. CFFTS GOVERNING DOCUMENTS (BYLAWS AND ARTICLES OF INCORPORATION) ARE AVAILABLE UPON REQUEST BY CONTACTING THE ORGANIZATION IN WRITING OR BY PHONE. INFORMATION ON HOW TO OBTAIN THE GOVERNING DOCUMENTS IS AVAILABLE ON THE WEBSITE, WWW.CFF.ORG/RESEARCH/CFFT. THE BOARD AND OFFICER CONFLICT OF INTEREST POLICY AND THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS ARE AVAILABLE ON THE WEBSITE, WWW.CFF.ORG/RESEARCH/CFFT/FINANCIALSTATEMENTS.
PART VII, SECTION A THE FOLLOWING IS AN ESTIMATE OF THE AVERAGE HOURS PER WEEK DEVOTED TO RELATED ORGANIZATIONS BY THE OFFICERS: CYSTIC FIBROSIS CYSTIC FIBROSIS FOUNDATION FOUNDATION GROUP RETURN TITLE HEADQUARTERS FOR THE CHAPTERS ----- ------------- ---------------------- PRESIDENT & CEO 36 4 EXEC. VICE PRESIDENT & COO 50 5 EXEC. VICE PRESIDENT & CFO 50 5
PART VII, SECTION A REPORTABLE COMPENSATION FROM THE ORGANIZATION THIS AMOUNT WAS PAID TO DR. TORPHY WITH RESPECT TO HIS SERVICES AS AN EMPLOYEE, WHICH TERMINATED ON 12/31/14. HE WAS PAID FOR THOSE SERVICES IN ACCORDANCE WITH THE ORGANIZATION'S STANDARD PAY PRACTICES, WHICH CAUSED HIS FINAL PAYCHECKS TO BE PAID IN THE FIRST TWO PAY DATES DURING 2015. THEREFORE, THE COMPENSATION IS REPORTABLE COMPENSATION FOR 2015. DR. TORPHY RECEIVED NO COMPENSATION AS CHAIRMAN OF THE BOARD OF DIRECTORS OF THE ORGANIZATION.
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 51056K
Schedule O (Form 990 or 990-EZ) 2015


Additional Data


Software ID:  
Software Version:  
SCHEDULE R
(Form 990)
Department of the Treasury
Internal Revenue Service
Related Organizations and Unrelated Partnerships
MediumBulletComplete if the organization answered "Yes" on Form 990, Part IV, line 33, 34, 35b, 36, or 37.
MediumBulletAttach to Form 990.
MediumBullet Information about Schedule R (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047
2015
Open to Public Inspection
Name of the organization
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC
 
Employer identification number

91-2059167
Part I
Identification of Disregarded Entities Complete if the organization answered "Yes" on Form 990, Part IV, line 33.
(a)
Name, address, and EIN (if applicable) of disregarded entity


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Total income


 		(e)
End-of-year assets


 		(f)
Direct controlling
entity










Part II
Identification of Related Tax-Exempt Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.
(a)
Name, address, and EIN of related organization


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Exempt Code section


 		(e)
Public charity status
(if section 501(c)(3))

 		(f)
Direct controlling
entity

 		(g)
Section 512(b)(13) controlled entity?
Yes No
(1)CYSTIC FIBROSIS FOUNDATION- HEADQUARTERS
6931 ARLINGTON RD

BETHESDA,MD20814
13-1930701 		RESEARCH DE 501(c)(3) 7 NA
 
 
No
(2)CYSTIC FIBROSIS FOUNDATION - GROUP
6931 ARLINGTON RD

BETHESDA,MD20814
13-6161105 		EDUCATION DE 501(c)(3) 7 CFF-HQ
 
 
No










For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50135Y
Schedule R (Form 990) 2015
Schedule R (Form 990) 2015
Page 2
Part III
Identification of Related Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a partnership during the tax year.
(a)
Name, address, and EIN of
related organization



 		(b)
Primary activity




 		(c)
Legal
domicile
(state or foreign
country)


 		(d)
Direct controlling
entity



 		(e)
Predominant income(related, unrelated, excluded from tax under sections 512-514)

(f)
Share of total income




 		(g)
Share of end-of-year
assets



 		(h)
Disproprtionate allocations?




 		(i)
Code V-UBI
amount in box 20 of
Schedule K-1
(Form 1065)
 		(j)
General or
managing
partner?



 		(k)
Percentage
ownership
Yes No Yes No












Part IV
Identification of Related Organizations Taxable as a Corporation or Trust Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.
(a)
Name, address, and EIN of
related organization
 		(b)
Primary activity
 		(c)
Legal
domicile
(state or foreign
country)
 		(d)
Direct controlling
entity
 		(e)
Type of entity
(C corp, S corp,
or trust) 		(f)
Share of total income
 		(g)
Share of end-of-year
assets
 		(h)
Percentage
ownership
 		(i)
Section 512(b)(13) controlled entity?
Yes No












Schedule R (Form 990) 2015
Schedule R (Form 990) 2015
Page 3
Part V
Transactions With Related Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34, 35b, or 36.
Note. Complete line 1 if any entity is listed in Parts II, III, or IV of this schedule.
Yes
No
1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?
a Receipt of (i) interest, (ii) annuities, (iii) royalties, or (iv) rent from a controlled entity .....................
1a
 
No
b Gift, grant, or capital contribution to related organization(s) ............................
1b
 
No
c Gift, grant, or capital contribution from related organization(s) ............................
1c
Yes
 
d Loans or loan guarantees to or for related organization(s) ............................
1d
 
No
e Loans or loan guarantees by related organization(s) ............................
1e
 
No
f Dividends from related organization(s) ............................
1f
 
No
g Sale of assets to related organization(s) ............................
1g
 
No
h Purchase of assets from related organization(s) ............................
1h
 
No
i Exchange of assets with related organization(s) ............................
1i
 
No
j Lease of facilities, equipment, or other assets to related organization(s) .......................
1j
 
No
k Lease of facilities, equipment, or other assets from related organization(s) ......................
1k
 
No
l Performance of services or membership or fundraising solicitations for related organization(s) .....................
1l
 
No
m Performance of services or membership or fundraising solicitations by related organization(s) .................
1m
 
No
n Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) ...................
1n
Yes
 
o Sharing of paid employees with related organization(s) ............................
1o
Yes
 
p Reimbursement paid to related organization(s) for expenses ............................
1p
 
No
q Reimbursement paid by related organization(s) for expenses ............................
1q
 
No
r Other transfer of cash or property to related organization(s) ............................
1r
 
No
s Other transfer of cash or property from related organization(s) ............................
1s
 
No
2
If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.
(a)
Name of related organization 		(b)
Transaction
type (a-s) 		(c)
Amount involved 		(d)
Method of determining amount involved





Schedule R (Form 990) 2015
Schedule R (Form 990) 2015
Page 4
Part VI
Unrelated Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990, Part IV, line 37.
Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.
(a)
Name, address, and EIN of entity 		(b)
Primary activity 		(c)
Legal domicile
(state or foreign
country) 		(d)
Predominant income (related, unrelated, excluded from tax under sections 512-514)

(e)
Are all partners
section
501(c)(3)
organizations? 		(f)
Share of total income




 		(g)
Share of
end-of-year
assets 		(h)
Disproprtionate allocations? 		(i)
Code V-UBI
amount in box 20
of Schedule K-1
(Form 1065) 		(j)
General or
managing
partner? 		(k)
Percentage
ownership
Yes No Yes No Yes No






























Schedule R (Form 990) 2015
Schedule R (Form 990) 2015
Page 5
Part VII
Supplemental Information
Provide additional information for responses to questions on Schedule R (see instructions).
Return Reference Explanation
Schedule R (Form 990) 2015

Additional Data


Software ID:  
Software Version: